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Abstract
Methyl methacrylate (MMA) is a respiratory irritant and dermal sensitizer that has been associated with occupational 
asthma in a small number of case reports. Those reports have raised concern that it might be a respiratory sensitizer. To 
better understand that possibility, we reviewed the in silico, in chemico, in vitro, and in vivo toxicology literature, and 
also epidemiologic and occupational medicine reports related to the respiratory effects of MMA. Numerous in silico 
and in chemico studies indicate that MMA is unlikely to be a respiratory sensitizer. The few in vitro studies suggest that 
MMA has generally weak effects. In vivo studies have documented contact skin sensitization, nonspecific cytotoxicity, 
and weakly positive responses on local lymph node assay; guinea pig and mouse inhalation sensitization tests have not 
been performed. Cohort and cross-sectional worker studies reported irritation of eyes, nose, and upper respiratory tract 
associated with short-term peaks exposures, but little evidence for respiratory sensitization or asthma. Nineteen case 
reports described asthma, laryngitis, or hypersensitivity pneumonitis in MMA-exposed workers; however, exposures were 
either not well described or involved mixtures containing more reactive respiratory sensitizers and irritants. The weight of 
evidence, both experimental and observational, argues that MMA is not a respiratory sensitizer.
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Introduction
Methyl methacrylate (MMA; C5H8O2; CAS No� 80-62-6) 
is an α,β-unsaturated ester monomer that is produced 
in  high  volumes  and  used  widely  to  make  polymers 
employed in a wide range of industrial and consumer 
applications,  including  transparent  impact-resistant 
plastic sheets (e�g�, Plexiglas®, Lucite®), dental and sur-
gical cements, surface coatings, and injection molding 
and  extrusion�  MMA  has  sometimes  been  viewed  as 
an  “innocuous  substance”  (Bratt  and  Hathway,  1977; 
Elovaara et al�, 1983) because of its very high reported 
LD50 value (Tansy et al�, 1980) and in vitro cytotoxicity 
that is substantially lower than that of other acrylate and 
methacrylate monomers (Fujisawa et al�, 2000; Geurtsen, 
2000; Schweikl et al�, 2001)�
In contrast to its relative lack of lethality, MMA is a 
recognized irritant and skin sensitizer� It was reported 
that MMA can cause “severe” skin and respiratory irrita-
tion, and it has mild dermal sensitizing potential in ani-
mal studies (ECETOC, 1995; EU, 2002; IPCS, 1998)� Both 
dermal sensitization and respiratory irritation have also 
been reported in workers and others exposed to MMA� 
Of greater potential concern is the possibility that MMA 
acts as a human respiratory sensitizer� Because of the 
large numbers of workers and consumers who might be 
exposed to MMA, the potential burden of MMA-induced 232  J. Borak et al.
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asthma could be considerable� However, that possibility 
has proven difficult to confirm in humans�
Despite  large  numbers  of  exposed  workers,  only  a 
small number of cases have been reported that seemingly 
link MMA with workplace asthma� Most of those cases 
involved mixed exposures: MMA is rarely encountered 
without additives (e�g�, stabilizers, accelerators, and/or 
antibiotics) and it is often used in mixtures with other 
acrylate and methacrylate monomers� In addition, it can 
be difficult to distinguish asthma induced by respiratory 
sensitizers from that due to respiratory irritants (Banks 
and Jalloul, 2007; Kimber et al�, 2007; Tarlo et al�, 2008; 
Tarlo and Broder, 1989; Tarlo and Malo, 2009)� Thus, it 
remains uncertain whether MMA poses significant risks 
of respiratory sensitization and asthma�
Recent  comprehensive  reviews  found  “no  convinc-
ing  evidence”  that  MMA  was  a  respiratory  sensitizer 
in humans (EU, 2002; IPCS, 1998), but the most recent 
(published  in  2002)  relied  on  a  literature  search  per-
formed in 1995� Accordingly, it seemed appropriate to 
update  that  literature  search  and  critically  review  the 
evidence regarding MMA and respiratory sensitization 
versus respiratory irritation�
Exposures and exposed populations
MMA is a widely used, high-volume synthetic chemical� 
Global  production,  estimated  to  be  1�4  million  metric 
tons in 1988 (IPCS, 1998), has expanded to an estimated 
annual  capacity  greater  than  2�5  million  metric  tons 
(>5�5 billion lbs) (Nexant, 2006)� In 1992, US production 
was estimated to be nearly 1�1 billion lbs (US EPA, 1994); 
since then US production has grown� There are also large 
and growing numbers of workers potentially exposed to 
MMA�  In  the  National  Occupational  Exposure  Survey 
(NOES), the National Institute for Occupational Safety 
and Health (NIOSH) found that during 1981–1983 there 
were 170,000 US workers exposed to MMA, nearly twice 
the 90,000 workers estimated to have been exposed dur-
ing 1972–1974 (NIOSH, 1990; Young, 2010)�
To better understand the nature of these worker expo-
sures,  it  is  useful  to  divide  industry  sectors  and  their 
workers into primary versus secondary MMA users� The 
former  includes  production  of  MMA,  MMA  polymer 
(pMMA) and methacrylate resins, as well as extrusion and 
casting of methacrylate sheets (e�g�, Plexiglas®, Lucite®)� 
These  activities,  performed  in  large  industrial  plants, 
currently employ more than 15,000 workers worldwide 
(Pemberton, 2010)� The secondary users, who represent 
the great majority of exposed workers, are comprised of 
a much larger number of generally small, nonindustrial 
facilities,  particularly  in  health  care  and  cosmetology� 
MMA-containing  materials  are  important  components 
of orthopedic bone cement, dental composites, and cos-
metic products used to sculpt and enhance fingernails�
The  precise  number  of  workers  actually  exposed 
to  MMA  in  secondary  industries  is  uncertain,  but 
the number is very large� NIOSH reported that about 
25,000 US health care workers were exposed to MMA in 
1981–1983 (NIOSH, 1990), and that number has greatly 
expanded� Consider, for example, that the number of 
hip replacement surgeries more than doubled world-
wide from the 1980s to the 1990s, and then redoubled 
over the next decade (Espehaug et al�, 2006; Katz, 2006; 
Kiefer, 2007; Malchau et al�, 2005)� Currently more than 
200,000  total  hip  replacements  are  performed  annu-
ally in the USA and more than 600,000 are performed 
annually in Europe� Likewise, between 1979 and 2009, 
the number of US dentists grew from 161,000 to about 
250,000,  whereas  the  number  of  US  dental  assistants 
increased from 129,000 to >400,000 (ADA, 2007, 2008; 
BLS, 2010; Kaiser, 2010)� During that time, acrylate com-
posites were increasingly adopted in place of amalgam 
fillings; a 2008 European Commission report described 
“hundreds of millions” of dental restorations performed 
annually (SCENIHR, 2008)� As for cosmetology, there 
were  more  than  155,000  manicurists  and  pedicurists 
in the USA in 2007 (US EPA, 2007)� In 1974, US Food 
and Drug Administration (FDA) banned nail products 
containing 100% MMA monomer (US FDA, 2010), but 
no  regulations  specifically  prohibit  the  use  of  MMA 
monomer at lower concentrations in cosmetic products 
and it continues to be found in nail products in the USA 
and many other countries (NICNAS, 2009; Work Safe 
Alberta, 2009)�
Levels  of  MMA  exposure  differ  widely  across  these 
various industries� As might be expected, the large facili-
ties of primary MMA users have been most systematically 
assessed�  Those  workers  generally  had  time-weighted 
average exposures at or below the current Occupational 
Safety and Health Administration (OSHA) occupational 
exposure limit of 100 ppm, but older reports described 
Abbreviations:
ACD, allergic contact dermatitis; 
BAL, bronchoalveolar lavage; 
GHS, Globally Harmonized System of Classification and 
Labeling of Chemicals; 
HMW, high molecular weight; 
LLNA, local lymph node assay; 
LMW, low molecular weight; 
LNC, lymph node cells; 
NOS, not otherwise specified; 
NSBH, nonspecific bronchial hyperreactivity; 
NSIC, nonspecific inhalation challenge; 
OA, occupational asthma; 
PEFR, peak expiratory flow rate; 
SIC, specific inhalation challenge; 
SPT, skin prick testing�Methyl methacrylate and respiratory sensitization  233
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short-term exposures of 180 ppm or more (CEFIC, 1995; 
Cromer, 1976; Della Torre et al�, 1982; Mizunuma et al�, 
1993; Monroe, 1981; Pausch et al�, 1994; Pickering et al�, 
1993; Tomenson et al�, 2000; Vos and Stephens, 2008)� 
By contrast, much higher exposures have been reported 
among secondary users� For example, daily mean con-
centrations up to 600 ppm were reported in workers who 
applied  MMA-containing  floor  coatings  (CEFIC,  1995; 
Lindberg  et  al�,  1991)�  Short-term  exposures  of  200  to 
>700 ppm have been detected while bone cement was 
being prepared in an operating room (Darre et al�, 1987; 
McLaughlin et al�, 1979; Pickering et al�, 1986)� In general, 
however, exposures have not been systematically studied 
in secondary user industries�
Respiratory sensitization versus respiratory 
irritation
Respiratory  sensitization  is  an  immunological  state  of 
the respiratory tract that results from specific adaptive 
immune  responses  to  antigenic  exposure,  leading  to 
heightened immunological responsiveness after subse-
quent exposures to the sensitizing antigen� In turn, such 
heightened respiratory tract responsiveness can result in 
allergic  reactions  characterized  by  airway  obstruction, 
nonspecific bronchial hyperreactivity, and inflammation 
that may present clinically as allergic rhinitis, asthma, 
and extrinsic allergic alveolitis (“hypersensitivity pneu-
monitis”) (Boverhof et al�, 2008; Isola et al�, 2008; Kimber 
et al�, 2007)� Agents that provoke such immune response 
are referred to as respiratory sensitizers, i�e�, “a substance 
that will induce a state of hypersensitivity of the airways 
following inhalation of the substance” (UN, 2007a)�
Low-molecular-weight (LMW) respiratory sensitizers 
share properties with the larger class of contact sensitiz-
ers,  but  their  specific  physiological  effects  result  from 
mechanistically different processes, and they are much 
fewer in number� Not more than about 40 LMW respi-
ratory sensitizers have been recognized, in contrast to 
greater than 500 contact skin sensitizers (Vandebriel and 
van Loveren, 2010)� The activity of both classes depends 
on their ability to form stable immunogenic complexes 
with  proteins;  their  bioavailability,  which  allows  them 
to reach epithelial tissues, engage dendritic cells, and be 
effectively presented to T lymphocytes; and their ability 
to induce production of cytokines that stimulate and dif-
ferentiate immunological reactions (DeJong et al�, 2009; 
Kimber and Dearman, 2005)� In addition, both classes of 
sensitizers test positively on standard skin sensitization 
assays� For such reasons, chemicals identified as contact 
sensitizers are often suspected of posing a potential for 
respiratory  sensitization�  On  the  other  hand,  contact 
sensitization and respiratory sensitization are different 
hypersensitivity phenomena caused by differing immu-
nological mechanisms (Enoch et al�, 2009; Kimber and 
Dearman, 2005; Rodford et al�, 2003)� Respiratory and 
contact  sensitizers  induce  different  cytokine  profiles, 
provoke responses by different T-cell populations, and 
most respiratory sensitizers (but not contact sensitizers) 
induce specific immunoglobulin E (IgE) (DeJong et al�, 
2009; Kimber et al�, 2010; Toebak et al�, 2006; Vandebriel 
and van Loveren, 2010)� The implications of these differ-
ences and the tests and assays used to identify and char-
acterize respiratory sensitizers are discussed below�
Respiratory  irritation,  by  contrast,  is  a  nonimmu-
nological state of the respiratory tract that results from 
inhalation of irritant substances at doses sufficient to 
cause inflammation� Such irritation may be mediated by 
neural reflexes (e�g�, “sensory irritation”) or cytotoxicity 
(Alarie, 1973b; Nielsen, 1991)� Respiratory irritants can 
cause syndromes that are clinically similar to those that 
result from respiratory sensitization and it can be dif-
ficult clinically to determine that an individual suffers 
sensitizer-  versus  irritant-induced  respiratory  disease� 
For that reason, pulmonary physicians speak of occupa-
tional asthma (OA), a category that includes both sen-
sitization and irritation (Bernstein et al�, 2006b; Francis 
et al�, 2007; Malo and Newman-Taylor, 2007; Tarlo et al�, 
2008); studies of OA do not often distinguish between 
hypersensitivity  and  irritant  causes  (Nicholson  et  al�, 
2005)� From a clinical perspective, such an approach is 
reasonable because treatments for both are similar and 
because sensitizers cause the great majority of OA, espe-
cially in well-controlled work sites where high-level irri-
tant exposures are rare (Gautrin et al�, 2006; McFadden 
and Gilbert, 1992; Nicholson et al�, 2005)�
However,  that  approach  provides  little  information 
about  the  etiology  and  mechanisms  of  disease�  Such 
information is important for selecting appropriate pre-
vention and control practices, which differ for sensitizers 
and irritants� In most cases, irritant effects can be avoided 
using industrial engineering and hygiene controls that 
reduce exposures to “safe” levels� By contrast, there are 
generally no “safe” exposure levels for agents to which 
workers and others have been sensitized; avoidance of 
further exposures often requires a change in job func-
tion or occupation� Moreover, respiratory sensitizers are 
regulated to a higher standard of safety and control under 
REACH  (Registration,  Evaluation,  Authorisation  and 
Restriction of Chemicals) and other regulatory schemes 
than respiratory irritants�
Because respiratory sensitization is widely regarded as 
an adverse effect of much concern and substantial mor-
bidity, and in order to implement necessary prevention 
and control procedures, considerable efforts have been 
made to develop methods to identify and characterize 
substances that act as respiratory sensitizers, with partic-
ular concerns for workplace chemicals� It is estimated that 
about 15% of adult asthma is attributable to occupational 
factors (Balmes et al�, 2003; Beach et al�, 2005; Tarlo et al�, 
2008) and up to 90% of those cases result from respiratory 
sensitization  (McFadden  and  Gilbert,  1992;  Nicholson 
et al�, 2005)� However, there has been particular difficulty 
identifying and characterizing the respiratory sensitiza-
tion  capacity  of  low-molecular-weight  (LMW;  <1 kDa) 
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the immunological mechanisms by which these agents 
induce respiratory hypersensitivity (Boverhof et al�, 2008; 
Isola et al�, 2008; Kimber et al�, 2007)� Identification of 
respiratory  sensitizers  is  also  challenging  because,  as 
noted above, the syndromes caused by sensitizers and 
irritants can be very similar�
Evaluations of the respiratory toxicity of MMA have 
faced the same challenges� Numerous studies have docu-
mented its capacity to cause contact skin sensitization, 
whereas others have documented MMA-induced irrita-
tion of the skin and respiratory tract, but only occasional 
reports suggest that MMA might also be a respiratory 
sensitizer� The extensive toxicology literature on MMA 
includes  in  silico  studies,  in  chemico  studies,  in  vitro 
studies, in vivo animal studies, and a variety of human 
observational studies that range from cohort studies to 
isolated case reports� The following sections of this report 
first describe the metabolism and mechanisms of action 
of MMA and then review the accumulated toxicology lit-
erature grouped according to study types�
Metabolism and mechanisms of action
The toxicity of MMA, particularly its capacity to cause 
irritation and to induce sensitization, is directly related 
to its metabolism and reactive chemistry� The principal 
metabolic pathway for MMA entails ester hydrolysis to 
methacrylic acid and methanol (FIgure 1), a process cat-
alyzed by carboxylesterase (Greim et al�, 1995)� In turn, 
both intermediary metabolites are further metabolized 
to carbon dioxide and water� Methacrylic acid is sequen-
tially transformed to methyl malonyl–coenzyme A (CoA) 
and succinyl-CoA, which enters the citric acid cycle and 
is thereby oxidized (Bratt and Hathway, 1977; Crout et al�, 
1982)� Methanol is transformed via formic acid to carbon 
dioxide� 
Hydrolysis and further metabolism of MMA occur rap-
idly following exposure� In rats administered C14-labeled 
MMA orally (5�7 or 120 mg/kg) or intravenously (5�7 or 
6�8 mg/kg), about 65% of the radioactivity was expired 
within 2 hours and 84–88% within 10 days; pulmonary 
excretion of unchanged MMA accounted for less than 
1�4% (Bratt and Hathway, 1977)� Following intraperito-
neal injection of C14-labeled MMA (35 or 45 mg/kg) in 
rats, 72% of the radioactivity was expired within 4 hours 
(Crout et al�, 1982)�
Such in vivo metabolic studies have not been described 
in humans, but in vitro studies of liver cells and olfactory 
and respiratory cells obtained from the nasal tracts of 
humans, rats, and hamsters have demonstrated qualita-
tively similar, but quantitatively different, across-species 
carboxylesterase  activity  for  MMA  (Mainwaring  et  al�, 
2001)� In those studies, human tissue was insufficient for 
determination of individual metabolic rate constants, but 
comparisons of pooled microsomal fractions indicated 
that human liver had a greater Vmax than rat or hamster 
livers  (Vmax:  494  versus  46�5  versus  137  nmol/min/mg 
protein), whereas the corresponding activity of human 
respiratory cell microsomes was lower (Vmax: 2�7 versus 
14�3  versus  3�6  nmol/min/mg  protein)�  Comparisons 
between  human  and  rat  olfactory  cell  S9  fractions 
revealed still greater interspecies differences (Vmax: 0�48 
versus 12 nmol/min/mg protein)�
The  relevance  of  olfactory  and  respiratory  carboxy-
lesterase activity to MMA-induced respiratory irritation 
and  cytotoxicity  has  also  been  demonstrated�  In  ani-
mal  studies,  high  level  MMA  inhalation  exposure  was 
cytotoxic to nasal epithelium, leading to inflammatory 
cell infiltration, degeneration, atrophy, and metaplasia 
(Chan et al�, 1988; Hext et al�, 2001; Mainwaring et al�, 
2001), effects caused by methacrylic acid–induced irrita-
tion� Inhibition of enzymic activity by bis(4-nitrophenyl)
phosphate  (BNPP),  a  carboxylesterase  inhibitor,  sig-
nificantly reduced the extent and severity of epithelial 
injury (Mainwaring et al�, 2001)� BNPP-induced carboxy-
lesterase  inhibition  also  significantly  reduced  deposi-
tion of inhaled MMA in the upper respiratory tract of 
anesthetized  rats  (Morris,  1992;  Morris  and  Frederick, 
1995)� Thus, both respiratory tract dose and cytotoxicity 
following inhalation exposure are determined by carbox-
ylesterase activity� In a similar manner, the importance 
of   carboxylesterase-mediated hydrolysis for the metabo-
lism of related acrylate and methacrylate esters has also 
been demonstrated (McCarthy and Witz, 1997)�
A  second  important  metabolic  pathway  for  MMA 
involves reaction with tissue nucleophiles via Michael 
addition on the electrophilic Cβ of the α,β-unsaturated 
carboxyl group (Freidig et al�, 1999; Greim et al�, 1995; 
McCarthy et al�, 1994)� The prototype for such reactions 
is  conjugation  with  glutathione  (GSH),  which  occurs 
spontaneously and enzymatically, leading to formation 
of thioethers and mercapturic acids� Increased urinary 
excretion of thioethers and depletion of hepatocyte GSH 
have  been  documented  following  in  vivo  and  in  vitro 
exposures to MMA and other acrylate and methacrylate 
esters (Delbressine et al�, 1981; Elovaara et al�, 1983)�
The  electrophilic  reactivity  of  low-molecular-weight 
molecules, as reflected by their interactions with gluta-
thione and other nucleophiles, is an important aspect of 
their ability to act as sensitizers (Enoch et al�, 2008, 2009, 
2010; Roberts et al�, 2007, 2008; Smith and Hotchkiss, 
2001)� In skin sensitization studies, a key early step in 
the process leading to sensitization is the formation of 
covalent adducts with a carrier protein, thereby forming 
an antigenic hapten-protein complex (Natsch and Emter, 
2008; Roberts et al�, 2008; Roberts and Aptula, 2008; Smith 
and Hotchkiss, 2001)� Such covalent protein binding has 
also been described as an “essential step” required for 
respiratory sensitization (Enoch et al�, 2009, 2010) and 
electrophilic  reactivity  is  said  to  predict  sensitization 
potential, although it is not the only important determi-
nant� Within mechanistic domains and subcategories of 
electrophiles, the ability of compounds to cause respira-
tory sensitization has been related to their relative elec-
trophilicity� Michael acceptor electrophiles, such as MMA 
and related esters, are predicted to be strong sensitizers Methyl methacrylate and respiratory sensitization  235
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Table 1�  Reactivity of MMA and other representative (meth)acrylates, respiratory sensitizers and irritants, dermal sensitizers, and non-
sensitizers.
Chemicals
Mechanistic 
category
LLNA EC3
Measures of electrophilicity
Log P
Electrophilic 
Index, ω
GSH depletion, KGSH  
(L mol−1 min−1)
GSH depletion,  
RC 50 (mM)
 (↑ value → ↓ 
reactivity)
(↑ value → ↑ 
reactivity)
(↑ value → ↑ 
reactivity)
(↑ value → ↓ 
reactivity)
Methyl methacrylate and other (meth) acrylates
Methyl methacrylate Michael  
addition
60–90 0.85 (9) 0.20 (12) 70 (7) 1.38
“Weak” (1) 0.33 (13) 74.1 (15)
  6 (14) 76 (17)
Methyl acrylate Michael  
addition
19.6 1.02 (9) 11.4 (15) 0.42 (15) 0.8
“Weak” (2) 52.0 (13)
  61 (14)
Ethyl methacrylate Michael  
addition
No data 0.83 (9) 0.058 (15) NRAS (7, 17) 1.94
0.139 (13)
4 (14)
Ethyl acrylate Michael  
addition
28 0.99 (9) 10.6 (15) 0.52 (7, 17) 1.32
“Weak” (3) 11.9 (16)
  26.6 (13)
  39.7 (12)
  57 (14)
Allyl methacrylate Michael  
addition
No data No data 0.51 (12) No data 2.12
3 (14)
Allyl acrylate Michael  
addition
No data 0.94 (9) 19.5 (9) 3.5 (17) 1.4
2-Hydroxypropyl 
methacrylate
Michael  
addition
“Non-sensitizer” 
(3)
No data 4 (14) 28 (7) 0.97
2-Hydroxyethyl 
methacrylate
Michael  
addition
“Non-sensitizer” 
(4)
No data 33 (8) No data 0.47
2-Hydroxyethyl acrylate Michael 1.4 No data 22.2 (16) 0.27 (7)  −0.21
addition “Moderate” (3) 50.9 (12)
    102 (14)
Representative respiratory sensitizers
Trimellitic anhydride Acylation 0.22 2.35 (10) No data No data 1.95
“Strong” (5)
2,4-TDI Acylation 0.11 1.37 (10) No data No data 3.74
(toluene diisocyanate) “Strong” (5) 1.23 (11)
Phthalic anhydride Acylation 0.36 2.61 (11) No data No data 1.6
“Strong” (5)
Known or suspected respiratory sensitizers
Formaldehyde Acylation 0.4 1.46 (11) No data No data 0.35
“Strong” (5)
Hydroquinone Michael  
Addition
0.11 No data No data 4.4 (7) 0.59
“Strong” (3)
Representative respiratory irritant
Acrolein Michael  
addition
0.86 No data No data 0.086 (17) −0.01
“Strong” (8)
Representative contact sensitizer
DNCB SnAr 0.04 3.32 (11) No data No data 2.17
(dinitrochlorobenzene) “Extreme” (1)
Representative non-irritant, non-sensitizer
Methyl tiglate Michael  
addition
No data 1.24 (10) 0.007 (15) NRAS (15, 17) 1.69
0.694 (9)
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(Natsch and Emter, 2008; Roberts et al�, 2007a), but there 
is  a  broad  spectrum  of  electrophilic  reactivity  across 
those esters (see Table 1 and discussion below)� However, 
electrophilicity alone cannot be used to directly compare 
sensitization potential across mechanistic categories and 
subdomains  (e�g�,  Michael  acceptors  versus  acylators 
versus SnAr) (Enoch et al�, 2009, 2010)�
Hydrolysis of MMA reduces its sensitization potential 
because,  under  physiological  conditions,  methacrylic 
and acrylic acids are not electrophilic or protein reactive 
(Frederick  and  Reynolds,  1989;  Smith  and  Hotchkiss, 
2001)� In rat studies, intraperitoneal (IP) administration of 
0�14 mM/kg (~14 mg/kg) MMA did not result in increased 
urinary excretion of thioethers, whereas thioether excre-
tion  was  significantly  increased  in  animals  pretreated 
with a carboxylesterase inhibitor (tri-o-tolyl phosphate) 
(Delbressine et al�, 1981)� In contrast to MMA, adminis-
tration of comparable doses of methyl acrylate resulted in 
demonstrable thioether excretion both with and without 
carboxylesterase inhibition� These findings suggest that 
hydrolysis is the principal pathway of MMA metabolism, 
that  electrophilic  reactions  via  Michael  addition  play 
only a minor role, and that such reactions occur only at 
high tissue concentrations (Greim et al�, 1995)�
In silico analyses
Background
Considerable effort has been made to identify LMW sen-
sitizers and characterize their sensitization potential by 
means of qualitative and quantitative structure-activity 
relationships  (SARs)  and  SAR  analyses�  SAR  analyses 
use  computational  methods  to  identify  submolecular 
structural features (i�e�, molecular fragments, functional 
groups)  that  have  been  associated  with  specific  bio-
logical effects, either subcellular effects, such as protein 
reactivity  and  up-regulation  of  specific  cytokines,  or 
clinical effects such as provocation of asthma (Gerberick 
et al�, 2008; Graham et al�, 1997; Patlewicz et al�, 2007)� 
Submolecular features identified in this way are referred 
to as “structural alerts�” The presence and pattern of par-
ticular structural alerts provide a basis for predictions 
that specific molecules cause particular biological effects� 
Such analyses are computer intensive, utilizing artificial 
intelligence software (i�e�, “expert systems”) to evaluate 
large data sets containing the physical properties, chemi-
cal properties, and biological activities of the chemicals 
under analysis�
A number of SAR expert systems have been developed 
and used to compare the molecular structures of LMW 
chemicals with known sensitizing or irritancy activity� An 
example is the relative alkylation index (RAI), which esti-
mates a compound’s relative degree of covalent binding 
with host carrier proteins (Roberts et al�, 2007a, 2009)� RAI 
is based on the understanding that sensitization depends 
quantitatively on the degree of such binding, which can 
be estimated by the rate constant for the reaction of the 
compound with specific nucleophiles� As described in fol-
lowing sections, various in silico, in chemico, and in vitro 
assays have been used to determine the rate constants 
for these analytical models� By comparing RAI values of 
106 LMW compounds with their corresponding in vivo 
local lymph node assay (LLNA) results, six “major reac-
tion mechanistic domains” were identified that served 
to predict the relative sensitization potency for 87 of the 
compounds (Roberts et al�, 2007a)� A related approach 
employed the electrophilic index (ω) to estimate the sen-
sitization potential of 19 LMW chemicals characterized 
as Michael acceptors (Enoch et al�, 2008)� Results showed 
“good agreement” with those of LLNA, but the sensitivity, 
specificity, and predictive values of the methods were not 
described�
A more clinical example of the uses of SAR was pro-
vided  by  five  analyses  that  used  different  software  to 
analyze  different  databases  to  compare  the  molecular 
structures of LMW chemicals known to cause asthma and 
other compounds known to not cause asthma� Although 
these five analyses employed different statistical proto-
cols, analyzed different chemical databases, and identi-
fied differing numbers and types of structural alerts, their 
results  were  surprisingly  similar  (Kimber  et  al�,  2007; 
Seed et al�, 2008)� The sensitivity of the expert systems 
for  identifying  the  respiratory  sensitizers  ranged  from 
85% to 96%, whereas their specificity ranged from 74% to 
Chemicals
Mechanistic 
category
LLNA EC3
Measures of electrophilicity
Log P
Electrophilic 
Index, ω
GSH depletion, KGSH  
(L mol−1 min−1)
GSH depletion,  
RC 50 (mM)
 (↑ value → ↓ 
reactivity)
(↑ value → ↑ 
reactivity)
(↑ value → ↑ 
reactivity)
(↑ value → ↓ 
reactivity)
    (1) Betts 2006 (9) Wondrousch 
2010
(9) Wondrousch 2010 (7) Schultz 2009 (18) NLM 
2010
    (2) Dearman 2007  (10) Enoch 2010 (12) Freidig 1999 (15) Bohme 2009  
    (3) Gerberick 2005 (11) Enoch 2009 (13) McCarthy 1994 (17) Yarbrough 2007  
    (4) Roberts 2007a   (14) Chan 2008    
    (6) Gerberick 2007b   (15) Bohme 2009    
    (7) Schultz 2009   (16) Roberts 2009    
    (8) Schultz 2007        
Key: NRAS: = not reactive at saturation.
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99% (Cunningham et al�, 2005; Graham et al�, 1997; Jarvis 
et al�, 2005; Karol et al�, 2001)� In almost every case, the 
expert systems correctly identified compounds that were 
not respiratory sensitizers, yielding an apparent negative 
predictive value (NPV) >95%� On the other hand, each 
system failed to identify at least some of the respiratory 
sensitizers�  To  calculate  the  positive  predictive  value 
(PPV) of these methods, it is necessary to know not only 
their sensitivity and specificity, but also the proportion 
of all chemicals that are actually respiratory sensitizers, 
i�e�, the prior probability� If the proportion of respiratory 
sensitizers was 1:30, then the PPV of those five systems 
would have ranged from 0�10 to 0�75, but if only 1 in 300 
chemicals was a respiratory sensitizer, the PPV would 
been only 0�01 to 0�22 (Seed et al�, 2008)� Because only 
a limited number of LMW respiratory sensitizers have 
been identified to date, it seems likely that the true prior 
probability  will prove relatively small, thus implying a 
small PPV for the method�
SAR analysis has been proposed for initial screening of 
potential sensitizers� An extensive literature documents 
its utility for contact sensitizers, but there is only lim-
ited experience for respiratory sensitizers and irritants 
(Gerberick  et  al�,  2008;  Patlewicz  et  al�,  2007;  Rodford 
et al�, 2003)� Because of their high NPV, SAR analyses 
seem  able  to  effectively  exclude  from  further  testing 
LMW chemicals that are not respiratory sensitizers� But 
because of their relatively low PPV, SAR analyses alone 
are probably not sufficient to conclude that a specific 
agent is a respiratory sensitizer�
In silico analyses of MMA
Electrophilic reactivity
The electrophilicity of MMA has been evaluated using 
two different in silico analytical systems� One approach 
predicted  the  electrophilic  index  (ω)  by  modeling  the 
rate constants of specific electrophile-nucleophile reac-
tions  based  on  their  ionization  potential  and  electron 
affinity, which are quantified in terms of their highest 
occupied molecular orbital (HOMO) and lowest unoc-
cupied molecular orbital (LUMO) energies (Enoch et al�, 
2009, 2010; Wondrousch et al�, 2010)� Increasing values 
of ω indicate increasing reactivity with nucleophiles� The 
second approach employed nuclearmagnetic resonance 
(NMR) spectroscopy to characterize the electron density 
of the β-carbon of the (meth)acrylate α-β-double bond 
(Fujisawa  and  Kadoma,  2009;  Ishihara  and  Fujisawa, 
2009)�  The  magnitude  of  NMR  shift  correlates  with 
electrophilic  reactivity�  For  example,  high  correlation 
(r2 = �998) was found between NMR results of 20 acrylates 
and methacrylates and their corresponding glutathione 
reactivity (Fujisawa and Kadoma, 2009)�
Table 1 presents the electrophilic index (ω) of MMA 
and  selected  acrylates,  methacrylates,  known  respira-
tory and contact sensitizers, a representative respiratory 
irritant, and a representative nonsensitizer, nonirritant� It 
can be seen that the electrophilic index (ω) values of MMA 
and other methacrylates were lower than corresponding 
values of acrylates and much lower than those of known 
respiratory sensitizers�
Structure-activity relationships
Schultz  and  colleagues  (Schultz  et  al�,  2007,  2009; 
Yarbrough  and  Schultz,  2007)  used  a  combination  of 
in chemico glutathione reactivity measures and in vivo 
LLNA data to identify reactive structural fragments within 
the subcategories of Michaels acceptors� They character-
ized  10  subcategories;  MMA  and  other  methacrylates 
were grouped into the subcategory associated with slow 
rates  of  reaction  and  weak  sensitizing  potential�  They 
attributed the lack of reactivity and sensitizing potency 
to the α-methyl substitution of the α-β-double bond�
Patlewicz et al� (Patlewicz et al�, 2007) evaluated the 
performance of three expert SAR models developed to 
identify contact skin sensitizers, not respiratory sensitiz-
ers, using a database of 211 LMW chemicals previously 
tested by LLNA (Gerberick et al�, 2005)� MMA was not 
included in the database, but there were other acrylate 
and  methacrylate  esters�  The  authors  concluded  that 
although  the  α-β-double  bond  fragment  of  the  meth-
acrylate structure is electrophilic and can act as a Michael 
acceptor, the presence of α-methyl substitution “desta-
bilizes  the  Michael  transition  state”  and  significantly 
reduces its capacity to sensitize� This finding supports 
the conclusion by McCarthy et al� (McCarthy et al�, 1994), 
who evaluated a different set of LMW chemicals that did 
include MMA�
Several  other  studies  performed  qualitative  SAR 
analyses to determine the types and numbers of func-
tional groups found on the molecules of LMW industrial 
chemicals that had been documented to cause respira-
tory sensitization and/or human asthma� Although not 
all of the following analyses specifically consider MMA, 
their findings are relevant� Agius and colleagues (Agius 
et al�, 1991, 1994; Agius, 2000; Seed and Agius, 2010) 
reviewed the literature on occupational asthma to iden-
tify LMW industrial chemicals with sufficient clinical or 
epidemiological evidence indicating that the chemical 
caused asthma� For those chemicals, the types and fre-
quency of functional molecular subgroups were deter-
mined and compared to the frequency of such groups 
for chemicals believed to not cause asthma� A major 
finding was that the likelihood of a LMW chemical caus-
ing respiratory sensitization and asthma increased sig-
nificantly if it had at least two reactive groups that could 
lead to protein cross-linking (Seed et al�, 2008), whereas 
monofunctional molecules (e�g�, MMA) posed smaller 
risks�
Graham  et  al�  (Graham  et  al�,  1997)  identified  40 
respiratory sensitizers, i�e�, LMW chemicals documented 
to elicit a decrease in forced expiratory volume in one 
second (FEV1) ≥20% within 24 hours of provocation chal-
lenge, which were nonmetallic and contained at least two 
contiguous nonhydrogen atoms� Two software systems 
were used to compare the molecular structures of those 
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not known to be sensitizers� The analyses and resulting 
SAR model were validated by means of a reiterative data 
withholding exercise� There were 16 molecular fragments 
(“biophores”) associated with the active chemicals (12 
with p <�05) and four fragments (“biophobes”) associ-
ated with the inactive chemicals (three with p <�05)� No 
fragment of MMA was on the list of biophores, but esters 
(CO-O-CH2-) were on the list of biophobes (p <�001)� 
Model validation indicated that sensitivity and specificity 
were both >95%�
Jarvis et al� (Jarvis et al�, 2005) performed SAR analy-
sis on 78 LMW chemicals reported to cause asthma in 
humans and 301 LMW industrial chemicals not known 
to be respiratory sensitizers� Logistic regression was used 
to  determine  the  statistical  associations  between  the 
asthmagens and 25 categories of molecular fragments� 
In light of those statistical associations, a “hazard index” 
was calculated that predicted whether each chemical was 
an asthma hazard� The SAR model was then validated on 
a second set of LMW chemicals that included 21 known 
asthmagens, 16 suspected asthmagens, and 77 nonsen-
sitizers� For the validation set, the model had a sensitiv-
ity of 86% and a specificity of 99%� MMA was one of the 
chemicals included in the analysis; it was classified as 
“inactive,” i�e�, it was predicted to not be an occupational 
asthma hazard�
Section summary
A limited number of SAR studies have considered the 
contact and respiratory sensitization potential of MMA� 
Two  groups  of  studies  found  that  a  methyl  group  on 
the α-carbon of the acrylate double bond substantially 
reduced sensitizing capacity and that the electrophilic 
reactivity  of  MMA  was  significantly  less  than  corre-
sponding acrylate esters� Three studies reported that the 
respiratory sensitization hazard of LMW asthmagens was 
substantially increased if they had at least two reactive 
functional groups; MMA has only one, the α-methyl sub-
stituted double bond� Another study of chemicals asso-
ciated with occupational asthma characterized esters as 
nonsensitizers� Finally, one SAR analysis with a model 
specificity of 99% concluded that MMA was “inactive” 
and not a respiratory sensitizer�
Although the number of SAR studies is limited, they 
provide a weight of evidence that MMA does not cause 
respiratory sensitization� However, the role of SAR analy-
ses for the identification of sensitizers remains limited; it 
is currently not sufficient to be regarded as “a standalone 
tool for hazard identification” (Patlewicz et al�, 2007)�
In chemico analyses
Background
In  chemico  analyses  can  be  used  to  characterize  the 
properties of LMW chemicals that impact their ability 
to react with proteins and other nucleophiles� One com-
monly used assay type measures the disappearance of a 
nucleophile mixed with the LMW chemical and/or the 
formation of adducts between that LMW chemical and 
the  nucleophile  (Vandebriel  and  van  Loveren,  2010)� 
Such assays yield quantitative data that are often reported 
as either of two related terms, RC50 or KGSH (Roberts et al�, 
2008; Vandebriel and van Loveren, 2010)� The RC50 is the 
concentration of electrophile required to deplete 50% of 
a  fixed  quantity  of  a  sulfhydryl-containing  compound 
(e�g�, GSH) in a fixed time period (Chipinda et al�, 2010)� 
The KGSH is the apparent rate constant for such a reac-
tion with glutathione (Bohme et al�, 2009)� More reactive 
chemicals have smaller RC50 and larger KGSH values than 
less reactive chemicals�
A  related  in  chemico  approach  to  characterize  the 
reactivity  of  LMW  compounds  is  the  peptide  reactiv-
ity assay (PRA), which measures the depletion of GSH 
or  other  synthetic  mononucleophilic  peptides  after 
treatment with an excess of electrophile (Aleksic et al�, 
2009; Gerberick et al�, 2004, 2007b, 2008; Roggen et al�, 
2008)� Results of PRA can be compared to estimates of 
sensitization potency derived from other tests, such as 
in vivo LLNA (Aleksic et al�, 2009; Gerberick et al�, 2004; 
Mutschler et al�, 2009)� Predictive accuracy for contact 
sensitizers up to 90% has been reported for PRA, but its 
predictive  accuracy  for  respiratory  sensitizers  has  not 
been determined� Published reports have not described 
use of PRA to differentiate respiratory sensitizers, con-
tact sensitizers, and respiratory irritants (Boverhof et al�, 
2008; Gerberick et al�, 2008; Kimber et al�, 2007; Roggen 
et al�, 2008)�
Hydrophobicity (i�e�, log P), another property of LMW 
chemicals that impacts their ability to covalently bond 
with the nucleophile groups of carrier proteins, has also 
been evaluated using in chemico analyses (Roberts et al�, 
2007;  Vandebriel  and  van  Loveren,  2010)�  It  has  been 
estimated that sensitization potential is about twice as 
dependent  on  electrophilic  reactivity  as  hydrophobic-
ity  (Roberts  et  al�,  2008)�  It  has  also  been  shown  that 
the cytotoxicity of acrylate and methacrylate esters was 
directly related to their lipid solubility (r2 of �718 and �950, 
respectively) (Yoshii, 1997)�
In chemico analyses of MMA
RC50 and KGSH assays
The RC50 values for MMA and a variety of other LMW 
chemicals were determined by Schultz and colleagues 
(Schultz et al�, 2009; Yarbrough and Schultz, 2007) using 
a spectrophotometric assay to measure sulfhydryl group 
depletion  following  2-hour  reactions  with  GSH�  They 
evaluated 83 Michael acceptor chemicals, including 10 
acrylates,  six  methacrylates,  and  one  dimethacrylate� 
Bohme et al� (Bohme et al�, 2009) used a modification 
of that method to determine RC50 values for 26 Michael 
acceptors,  including  MMA  and  five  other  (meth)
acrylates�
The KGSH for various electrophilic Michael acceptors 
have  been  calculated  by  measuring  the  rates  of  GSH 
depletion  under  controlled  conditions�  Freidig  et  al� 
(Freidig  et  al�,  1999)  evaluated  six  acrylate  and  seven Methyl methacrylate and respiratory sensitization  239
© 2011 Informa Healthcare USA, Inc. 
methacrylate esters including MMA� Esters were incu-
bated with GSH at 20°C and pH 8�8 for 1 hour (acrylate 
esters) or 24 hours (methacrylate esters)� GSH depletion 
was measured by high-performance liquid chromatog-
raphy (HPLC)� Chan and O’Brien (2008) incubated five 
acrylates and five methacrylates, including MMA, with 
GSH at 25°C and pH 8�0 and measured the remaining 
GSH by spectrophotometry at various times from 10 to 
180 minutes� Bohme et al� (2009) and Wondrousch et al� 
(2010) incubated 26 Michael acceptors, including MMA 
and five other (meth)acrylates, with GSH at 25°C and pH 
7�4 and measured GSH depletion and oxidation using 
Ultraviolet-visible spectroscopy (UV-VIS) at up to eight 
time points per reaction� Roberts and Nash (Roberts and 
Natsch, 2009) incubated 26 LMW chemicals, including 
acrylates but not MMA, with a SH-based peptide (Cor1C-
420) at 25°C and pH 7�5� They used liquid chromatogra-
phy–mass spectrometry (LC-MS) at 30 to 1440 minutes to 
measure peptide depletion and oxidation, and to charac-
terize adduct formation�
Table 1 shows the RC50 and KGSH values of MMA, other 
representative  acrylates  and  methacrylates,  a  respira-
tory irritant (acrolein), and a nonirritant/nonsensitizer 
(methyl tiglate)� It can be seen that methacrylates are less 
reactive than acrylates: the RC50 values of the methacry-
lates are more than 100-fold greater and the KGSH values 
are 10- to 190-fold smaller than the values for the corre-
sponding acrylates� MMA is at the low end of the reac-
tivity range� Based solely on GSH reactivity, one would 
predict that methacrylate esters would be substantially 
less potent sensitizers than corresponding acrylates and 
that MMA would be among the least potent�
Peptide reactivity assay
In chemico PRA analyses have not been used to charac-
terize the reactivity of MMA, although other (meth)acry-
lates have been evaluated (Aleksic et al�, 2009; Gerberick 
et al�, 2007b)�
Hydrophobicity (log P)
As seen in Table 1, the log P of methacrylate and acrylate 
esters increases as the length of their alkyl side chains 
increase� In addition, α-methyl substitution of the α-β-
double bond increases the hydrophobicity of the ester 
molecules; thus the log P of methacrylates is about 50% 
greater than corresponding acrylates� MMA is among the 
least  hydrophobic  of  the  methacrylates�  However,  the 
increased log P of the methacrylates compared to acry-
lates  is  relatively  small,  compared  to  the  substantially 
greater increased GSH reactivity of the acrylates�
Section summary
A  limited  number  of  in  chemico  analyses  have  deter-
mined the thiol reactivity and hydrophobicity of MMA 
and  other  acrylates  and  methacrylate  esters�  Because 
of its relatively low electrophilic reactivity as contrasted 
with  those  other  esters  and  relatively  low  log  P,  one 
would expect that MMA has comparatively low sensitiz-
ing potential�
In vitro testing
Background
Several  in  vitro  approaches  have  been  used  to  char-
acterize  the  contact  sensitization  potential  of  LMW 
compounds�  One  approach,  cellular  response  assays, 
determines the response of cultured cells incubated with 
specific test chemicals� Such in vitro studies can deter-
mine secreted or intracellular cytokine profiles in kera-
tinocytes, dendritic cells (DCs), peripheral white blood 
cells,  T  cells,  respiratory  epithelial  cells,  and  alveolar 
macrophages (Cameron et al�, 1999; Corsini et al�, 2009; 
Gosepath et al�, 2007; Liu et al�, 1999; Muller et al�, 1996; 
Toebak et al�, 2006; Vandebriel et al�, 2005)� Cytokines 
are immune system signaling proteins that are central 
to the stimulation and differentiation of immunological 
reactions� A common classification distinguishes proin-
flammatory Th1-type cytokines (e�g�, interleukin-2 [IL-2], 
interferon γ (IFN-γ), tumor necrosis factor β) from anti-
inflammatory Th2-type cytokines (e�g�, IL-4, IL-5, IL-10)� 
Th1 cytokines are closely associated with enhanced cel-
lular immune responses and contact skin sensitization, 
whereas Th2 cytokines favor antibody responses (Berger, 
2000; Desai and Brightling, 2009; Kimber and Dearman, 
2005)� Respiratory sensitization is “a classical example” 
of Th2-mediated disease (Toebak et al�, 2006)�
However,  such  studies  have  been  mainly  used  to 
evaluate contact sensitizers, not respiratory sensitizers� 
Moreover, some researchers have noted that dendritic 
cell responses were relatively “modest,” were “not suffi-
ciently resilient to identify allergens,” and demonstrated 
considerable  “donor-to-donor  response  variations” 
even  when  testing  potent  contact  sensitizers  (Ryan 
et al�, 2009; Toebak et al�, 2009)� Accordingly, an in vitro 
model using such cell lines for identifying respiratory 
sensitizers “is currently lacking” (Vandebriel and van 
Loveren,  2010)�  By  contrast,  evidence  suggests  that 
IL-18, a cytokine produced in dermal (Stoll et al�, 1997) 
and respiratory epithelium (Cameron et al�, 1999), may 
play a useful role for identification and discrimination of 
contact sensitizers, respiratory sensitizers, and irritants� 
For example, Corsini et al� (Corsini et al�, 2009) incu-
bated human keratinocytes with one of three respira-
tory sensitizers, nine contact sensitizers, or four potent 
irritants� At noncytotoxic levels, IL-18 was induced by 
the contact sensitizers, but not by the respiratory sensi-
tizers or irritants�
To date, cellular response assays have been employed 
mainly in experimental settings to characterize responses 
to a limited number of known, potent contact sensitizers, 
but not respiratory sensitizers� There are few published 
data  indicating  their  ability  to  discriminate  between 
weak sensitizers and irritants and they have apparently 
not been used to characterize the respiratory sensitiza-
tion potential of unknown compounds�240  J. Borak et al.
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A second approach used by some researchers is an 
in  vitro  version  of  the  peptide  reactivity  assay  (PRA) 
described above, which has more commonly been per-
formed as an in chemico analysis�
In vitro testing of MMA
Cellular response assays
Gosepath  et  al�  (Gosepath  et  al�,  2007)  measured 
cytokine  release  and  expression  of  corresponding 
mRNAs in 22 primary cell cultures containing epithe-
lial and fibroblast cells from the inferior nasal turbinate 
tissue  of  healthy  individuals�  Cultures  were  exposed 
to 50 or 200 ppm MMA for 4 or 24 hours, after which 
cytokine and mRNA levels were determined� Controls 
were exposed to “synthetic air�” Levels of interleukin-1β 
(IL-1β),  IL-6,  IL-8,  tumor  necrosis  factor  α  (TNFα), 
granulocyte-macrophage  colony-stimulating  factor 
(GM-CSF) and monocyte chemotactic protein 1 (MCP-1) 
were  measured  in  culture  supernatant  by  enzyme-
linked  immunosorbent  assay  (ELISA)�  Quantitative 
polymerase chain reaction (Q-PCR) was used to mea-
sure intracellular levels of the corresponding mRNAs� 
Levels of mRNAs for IL-1β, IL-6, IL-8, TNFα, and MCP-1 
were increased after 4-hour exposure to 50 ppm, but 
not  200 ppm;  by  24  hours  the  elevated  mRNA  levels 
had regulated back to control levels� Cytokine protein 
levels were not increased after 4- or 24-hour exposures 
at either exposure level� Protein levels of the proinflam-
matory cytokine IL-1β were consistently low, whereas 
levels of TNFα and GM-CSF actually declined during 
exposure� The authors concluded that MMA exposure 
to 50 or 200 ppm did not induce lasting up-regulation 
of inflammatory mediators�
Liu et al� (Liu et al�, 1999) measured lymphocyte trans-
formation and release of three cytokines, IL-6, TNFα, and 
IFN-γ, in human whole-blood cultures from 10 healthy 
individuals� Cells were incubated with five MMA con-
centrations from 0�1 to 100 mmol/L (≈10 to 10,000 mg/L); 
cytotoxicity was seen at levels >30 mmol/L� The cells were 
tested with or without stimulation by phytohemaggluti-
nin (PHA) or Staphylococcus aureus protein A (SAP) and 
cytokines were measured daily for 6 days using ELISA� 
Compared  to  controls,  none  of  the  MMA  exposures 
induced  lymphocyte  transformation  as  determined  by 
incorporation of labeled thymidine� Release of cytokines 
was  inconsistent�  Levels  of  IFN-γ  decreased  under  all 
exposure conditions and times� Levels of IL-6 showed a 
nonsignificant increase in unstimulated cells, a signifi-
cant increase occurred with PHA stimulation, but appar-
ent inhibition was noted in SAP-stimulated cells� TNFα 
levels were increased only on day 1 in unstimulated cells, 
but no increase was noted in cells stimulated with PHA 
or SAP�
Peptide reactivity assay
McCarthy et al� (McCarthy et al�, 1994) determined the 
electrophilic  reactivity  of  MMA  with  GSH  and  com-
pared  it  to  the  reactivity  of  three  acrylate  and  three 
methacrylate  esters  (Table  1)�  Esters  were  incubated 
with GSH and red blood cells for 1 hour at 37°C and pH 
7�4� Declines in free-sulfhydryl levels were measured as 
changes in optical density, and apparent rate constants 
were determined for the reactions of each ester with 
GSH� Comparisons of corresponding pairs of acrylate 
and methacrylate esters indicated that α-methyl substi-
tution decreased ester reactivity toward nucleophiles� 
In particular, the apparent rate constant for the reaction 
of MMA with GSH was only 0�625% that for the reaction 
of methyl acrylate with GSH, indicating levels of reactiv-
ity that were substantially smaller than those of similar 
acrylate  esters�  The  apparent  rate  constant  for  MMA 
determined by McCarthy et al� was similar to the values 
determined in the in chemico studies discussed above 
(Table 1)�
Section summary
There has been only very limited in vitro testing of MMA 
for the purpose of characterizing its sensitization poten-
tial� The limited published data indicate that its effects 
are generally weak and they provide no evidence that 
MMA is a respiratory sensitizer�
In vivo animal studies
Background
There are currently no recognized and validated in vivo 
test  methods  to  identify  LMW  respiratory  sensitizers 
(Basketter et al�, 2009b; UN, 2007a; Vandebriel and van 
Loveren, 2010)� The animal species most often used for 
respiratory sensitization testing are the mouse and guinea 
pig (Briatico-Vangosa et al�, 1994; Karol, 1994; Pauluhn 
and Mohr, 2005)� Both species are listed by the Globally 
Harmonized  System  of  Classification  and  Labeling  of 
Chemicals (GHS) as appropriate “under certain circum-
stances” for evaluating the relative allergenicity of high-
molecular-weight  (HMW)  proteins  (UN,  2007b),  but 
there has been only limited experience in their use for 
testing LMW sensitizers� By contrast, a variety of animal 
models have been used to study the adverse respiratory 
effects of MMA exposures, but most did not specifically 
distinguish between respiratory irritation and respiratory 
sensitization� In addition, numerous studies have evalu-
ated the capacity of MMA to induce contact skin sensi-
tization� Summarized below are the animal studies that 
evaluated MMA-induced nonspecific respiratory effects, 
sensory irritation, respiratory sensitization, and contact 
skin sensitization�
Nonspecific respiratory effects
Numerous  experimental  studies  have  evaluated  the 
respiratory effects of acute, subchronic and chronic MMA 
inhalation in mice, rats, dogs, and hamsters� However, 
those  studies  did  not  distinguish  sensitization  from 
irritation� Most found evidence that MMA caused dose-
related cytotoxicity to respiratory epithelium in the nose, 
trachea,  and/or  lung  parenchyma�  Observed  effects, Methyl methacrylate and respiratory sensitization  241
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which were not species specific, included edema, inflam-
matory cell infiltration, degeneration, and atrophy� These 
studies will not be further detailed because they did not 
address issues of respiratory sensitization and because 
they have been well reviewed elsewhere (US EPA, 1998; 
EU, 2002; IPCS, 1998)�
Sensory irritation
“Sensory irritation” refers to a family of reflex-mediated 
physiological  responses  resulting  from  stimulation  of 
trigeminal nerve endings (Alarie, 1973a; ASTM, 2004; 
Nielsen,  1991)�  The  basis  of  sensory  irritation  testing 
(“Alarie  test”)  is  reduction  of  respiratory  frequency 
caused by inhalation exposure� Most often performed 
in Swiss Webster mice exposed nose-only for 10 to 30 
minutes, the test is “positive” if respiration frequency 
is reduced by 50%� The potency of a sensory irritant is 
typically expressed as the concentration necessary to 
achieve a 50% reduction in respiratory frequency (RD50) 
(Alarie et al�, 1995)� If increasing exposure does not result 
in such a 50% reduction, the agent is regarded as “not 
a sensory irritant,” although some toxicologists refer to 
slight or transient decreases in respiratory frequency as 
“mild sensory irritation” (Stadler, 1993)� Notably, this is 
not a test of cytotoxicity or corrosivity (Kuwabara et al�, 
2007)  and  concerns  have  been  raised  that  cytotoxic 
effects can occur at exposure levels that do not cause 
“sensory irritation” (Bos et al�, 2002; Zissu, 1995)�
Sensory  irritation  testing  has  been  performed  for 
MMA, methacrylic acid, and several other acrylate and 
methacrylate compounds� MMA and ethyl methacrylate 
were judged to not be sensory irritants; neither caused 
a 50% reduction of respiratory frequency, although each 
demonstrated  transient  “mild”  effects  (Stadler,  1993), 
and methacrylic acid was positive for sensory irritation, 
but demonstrated only weak potency (RD50: 22,000 ppm) 
(Stadler,  1993)�  By  contrast,  ethyl  acrylate  and  acrylic 
acid were substantially more potent with RD50 values of 
315 ppm (DeCeaurriz et al�, 1981) and 685 ppm (Buckley 
et al�, 1984), respectively�
These results are consistent with the physicochemical 
properties of methacrylates� The sensory irritant potency 
of individual chemicals is related to their reactivity with 
protein sulfhydryl groups (Alarie, 1973a, 1973b; Nielsen, 
1991)� As discussed above, α-methyl substitution of the 
unsaturated carboxyl group of methacrylates and meth-
acrylic acid reduces their thiol reactivity as compared to 
the activities of corresponding unsubstituted acrylates 
and acrylic acid� In addition, it is likely that MMA-induced 
sensory irritation would depend on its hydrolysis to meth-
acrylic acid (Nielsen, 1991), a corrosive but weak sensory 
irritant� Thus it is not surprising that MMA causes dose-
related cytotoxicity to respiratory epithelium, but little or 
no sensory irritation�
Respiratory sensitization
A  number  of  in  vivo  animal  testing  methods  have 
been used to characterize the sensitization potency of 
individual chemicals and their potential to specifically 
cause respiratory sensitization�
Guinea pig inhalation test
In  this  test,  the  respiratory  sensitization  capacity  of 
individual  chemicals  is  evaluated  by  determining  the 
pulmonary  responses  to  inhalation  exposure  in  sensi-
tized guinea pigs (Karol, 1994)� Initial sensitization can 
be induced by inhalation or dermal exposure followed 
several weeks later by inhalation challenge (Karol et al�, 
1985;  Pauluhn  and  Mohr,  2005;  Sarlo  and  Ritz,  1997)� 
Utility of this test derives from the fact that guinea pigs 
have challenge-induced pulmonary reactions similar to 
human asthma (Pauluhn and Mohr, 2005)�
There  are  several  important  limitations  to  this  test� 
Although the guinea pig response seems similar to clini-
cal  responses  in  humans,  respiratory  hypersensitivity 
in guinea pigs is primarily mediated by immunoglobu-
lin G1 (IgG1), whereas humans develop predominantly 
IgE-mediated hypersensitivity responses (Pauluhn and 
Mohr, 2005; Pretolani and Vargaftig, 1993)� Also, guinea 
pigs  “respond  vigorously”  to  inhaled  irritants,  leading 
to  asthma-like  bronchospasm  (Briatico-Vangosa  et  al�, 
1994; Kimber et al�, 2007; Pauluhn and Mohr, 2005; Sarlo 
and  Ritz,  1997)�  Because  MMA  and  most  other  LMW 
respiratory sensitizers have irritant properties (Pauluhn 
and Mohr, 2005), distinguishing between sensitizer- and 
irritant-induced effects may be difficult� Incorporation of 
a nonsensitized challenge group and use of smaller non-
irritating exposure doses facilitate distinguishing irritants 
from sensitizers (Karol, 1994)� Only a limited number of 
LMW chemicals have been tested and there are insuffi-
cient data to determine the test’s sensitivity, specificity, 
and  predictive  value  (Boverhof  et  al�,  2008;  Sarlo  and 
Karol, 1994; Seed et al�, 2008)�
Mouse IgE test
This test measures IgE in BALB/c mice or Brown Norway 
rats  following  induction  of  sensitization�  Exposure 
involves  serial  dermal  applications  followed  14  to  21 
days later by blood sampling and measurement of IgE 
(Briatico-Vangosa et al�, 1994; Karol, 1994; Pauluhn and 
Mohr,  2005)�  The  presence  of  antigen-specific  IgE  or 
an  increase  in  total  IgE  provides  qualitative  evidence 
of  a  compound’s  potential  as  a  respiratory  sensitizer� 
Although  the  test  yields  quantitative  results,  the  mag-
nitude of IgE response does not necessarily serve as a 
quantitative estimate of sensitizing potential (Boverhof 
et al�, 2008; Briatico-Vangosa et al�, 1994; Isola et al�, 2008; 
Kimber et al�, 2007; UN, 2007a)�
In vivo cytokine profiling
In vivo cytokine profiling involves characterization of the 
cytokines produced by lymph node cells (LNCs) draining 
the areas where LMW sensitizers were applied (de Jong 
et al�, 2009; Dearman et al�, 2003a, 2003b)� Respiratory 
sensitization  is  generally  associated  with  secretion 
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sensitization and allergic contact dermatitis (ACD) are 
associated with inflammatory Th1 cytokines� Respiratory 
irritation  is  not  dependent  on  T-helper  cells  and  irri-
tant exposure does not normally lead to either of those 
cytokine patterns�
Cytokine profiling is most often performed in BALB/c 
mice  sensitized  with  serial  skin  applications  of  test 
chemical� About 13 days after initial exposure, draining 
lymph  nodes  are  excised  and  LNCs  are  cultured  with 
and without mitogenic stimulation (e�g�, concavalin A)� 
A similar protocol has been adapted to inhalation expo-
sure� Typically, mice are sensitized by inhalation on 3 
consecutive days; 3 days later the draining lymph nodes 
are excised and treated as described above (de Jong et al�, 
2009)�  In  both  approaches,  the  culture  supernatant  is 
analyzed for cytokine protein by ELISA or cytokine bead 
array�  An  alternative  approach  involves  measurement 
of cellular cytokine mRNA (Dearman et al�, 1996, 2008; 
Hayashi et al�, 2001; Kimber et al�, 2007)�
Despite its theoretical attraction, the practical value of 
cytokine profiling is uncertain� In some studies, expected 
cytokine patterns were not found after sensitizer expo-
sures (de Jong et al�, 2009; Dearman et al�, 2003b; Selgrade 
et al�, 2006; Vandebriel et al�, 2000)� In others, exposure 
led to co-expression of Th1 and Th2 cytokines such that 
distinctions between contact and respiratory sensitizers 
were blurred (Arts and Kuper, 2007; de Jong et al�, 2009; 
Ulrich  et  al�,  2001)�  Moreover,  discordance  has  been 
reported  between  the  respiratory  response  predicted 
to occur on the basis of measured cytokine profiles and 
those actually observed (Pauluhn, 2008; Selgrade et al�, 
2006)�  Accordingly,  cytokine  profiling  is  viewed  as  a 
promising  approach  but  one  that  requires  additional 
work to optimize and validate testing protocols and test 
endpoints (Kimber et al�, 2007; Roggen et al�, 2008; Seed 
et  al�,  2008;  Selgrade  et  al�,  2006;  Vandebriel  and  van 
Loveren, 2010)�
Local lymph node assay
Local lymph node assay (LLNA) has been adopted as a 
stand-alone  test  by  the  National  Toxicology  Program 
(ICCVAM,  1999)  and  as  the  method  of  choice  under 
REACH (OECD, 2002, 2009; van Loveren et al�, 2008) for 
evaluation  of  contact  skin  sensitization�  As  described 
below, LLNA has also been performed following inhala-
tion exposure to characterize the potential for respiratory 
sensitization� The test measures lymphocyte proliferation 
in lymph nodes draining the site where chemicals were 
applied�  The  method  assumes  that  LNC  proliferative 
responses are causally and quantitatively associated with 
the  effectiveness  of  sensitization  induction  (ECETOC, 
2003, 2008), yielding results that quantitatively describe 
relative  sensitizing  potency,  which  correlates  with 
human sensitization thresholds (Loveless et al�, 2010; van 
Loveren et al�, 2008)� Although initially used to evaluate 
induction of sensitization by skin exposure, recent stud-
ies  describe  its  use  for  evaluating  inhalation-induced 
sensitization (Arts et al�, 2008; de Jong et al�, 2009)�
LLNA is usually performed in CBA or BALB/c mice� In 
a standard dermal LLNA, the chemical or a vehicle-only 
control is applied to the dorsum of the ears on 3 con-
secutive days� Three days later, the mice are injected with 
radiolabeled  thymidine�  After  five  hours,  the  draining 
auricular lymph nodes are excised and incorporation of 
radiolabel is measured by scintillation counting� At least 
three serial dilutions of the chemical are applied (Arts 
et al�, 2008; de Jong et al�, 2009)� Results for test chemicals 
and vehicle controls are compared and expressed as a 
stimulation index (SI), calculated by dividing the scintil-
lation counts for each chemical dilution or duration (per 
mouse or per lymph node) by the corresponding counts 
for  the  vehicle-only  control�  A  chemical  is  considered 
“positive” and labeled a sensitizer if it induces an SI ≥ 
3 at any concentration or duration� However, some irri-
tants (e�g�, sodium lauryl sulfate) are reported to cause 
false positive LLNA (Basketter et al�, 2009a; Roberts et al�, 
2007b)�
The concentration or exposure duration correspond-
ing to SI = 3 is referred to as the chemical’s EC3, and that 
value  has  been  used  to  classify  sensitization  potential 
(Basketter et al�, 2000; ECETOC, 2008; Gerberick et al�, 
2007a;  Griem  et  al�,  2003;  van  Loveren  et  al�,  2008)� 
ECETOC defines four potency classifications on the basis 
of EC3 for chemicals tested by dermal exposure (Table 2) 
(ECETOC, 2008)�
Although mainly used for dermal sensitizers, LLNA 
can also provide information relevant to respiratory sen-
sitization� “Respiratory LLNA” has been performed using 
the inhalation exposures and measurement of lympho-
cyte proliferation in the mandibular lymph nodes drain-
ing the upper respiratory tract (Arts et al�, 2008)� For such 
testing, mice are exposed nose-only to the chemical or 
vehicle-only control over a range of exposure durations, 
e�g�,  45–360 min/day  for  3  days�  Three  days  later,  after 
injection of labeled thymidine, the mandibular lymph 
nodes are excised and treated as above (Arts et al�, 2008; 
de Jong et al�, 2009)� Profiling of cytokines secreted by the 
draining lymph node cells after inhalation exposure has 
also been proposed as a basis for distinguishing between 
contact sensitizers, respiratory sensitizers, and irritants 
(de Jong et al�, 2009)�
The  “inherent  sensitizing  potential  of  the  chemi-
cal (potency)” is viewed as the most important factor 
external  to  the  host  for  induction  and  elicitation  of 
respiratory sensitization (Kimber et al�, 2007) and EC3 
has been proposed as the best approach for predicting 
sensitizing potency (Loveless et al�, 2010)� Almost all 
Table 2�  Relative skin sensitization potency of contact allergens 
based on LLNA (ECETOC, 2008).
Potency rating
EC3 
concentration (%)
Extreme <0.1
Strong ≥0.1≤ to ≤1.0
Moderate ≥1.0≤ to ≤10
Weak ≥10Methyl methacrylate and respiratory sensitization  243
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LMW  respiratory  sensitizers  yield  positive  results  on 
dermal LLNA, but most LMW chemicals with positive 
dermal  LLNA  are  not  respiratory  sensitizers  (Kimber 
et al�, 2007)� Thus, a negative LLNA implies that a tested 
chemical lacks respiratory sensitization potential (Arts 
et al�, 2008; Boverhof et al�, 2008; Kimber et al�, 2007; 
Roggen et al�, 2008)�
MMA testing
Guinea pig inhalation test�  Use of the guinea pig inhala-
tion test has not been described for testing of MMA�
Mouse IgE test�  Use of the Mouse IgE Test has not been 
described for testing of MMA�
In vivo cytokine profiling�  Use of in vivo cytokine profiling 
has not been described for testing of MMA�
Local lymph node assay�  Betts et al� (Betts, 2004; Betts 
et al�, 2006) tested MMA using LLNA in CBA/Ca mice 
using two different solvent vehicles for skin application� 
In one test MMA was dissolved in pure acetone, and in the 
other MMA was dissolved in an acetone-olive oil mixture� 
MMA was weakly positive in both LLNA, with EC3 values 
of 90% and 60%, respectively� By contrast, a positive con-
trol contact sensitizer, 2,4-dichloronitrobenzene (DNCB), 
had an EC3 value of 0�036%, implying 3000-fold greater 
sensitizing potential� Based on LLNA results, the relative 
sensitizing potency of MMA can be compared to those of 
four acrylate monomers tested by the same researchers 
according to the same protocol (Dearman et al�, 2007)� As 
shown in Table 1, MMA is a substantially weaker sensi-
tizer than most other methacrylates and acrylates�
In an early version of LLNA, Bull et al� (Bull et al�, 
1985) measured lymphocyte proliferation in the drain-
ing lymph nodes of guinea pigs after topical application 
of MMA dissolved in acetone-olive oil� Proliferation was 
scored by a microscopic cell-counting method� MMA 
exposure  caused  no  increased  proliferation�  By  con-
trast, methyl acrylate caused a significantly increased 
proliferation  and  was  judged  a  “medium  potential 
sensitizer�”
Contact skin sensitization
Background
Concerns that MMA might cause respiratory sensitiza-
tion  derive  in  part  from  its  capacity  to  cause  allergic 
contact dermatitis (ACD) in humans (US EPA, 1998; EU, 
2002; IPCS, 1998) and numerous in vivo animal studies 
have  been  performed  to  characterize  MMA  skin  sen-
sitization� In addition to LLNA (described above), two 
other methods acceptable to US EPA and OECD (US EPA, 
2003; OECD, 1992) for testing skin sensitization potential 
are the guinea pig maximization test (Magnusson and 
Kligman,  1970;  Wahlberg  and  Boman,  1985)  and  the 
Buehler test (Buehler, 1965; Robinson et al�, 1990)� Under 
GHS (UN, 2007a), other “well-validated” methods such 
as the mouse ear swelling test (Gad et al�, 1986) may also 
be used� Interpretation of test results is generally qualita-
tive and criteria vary between methods and laboratories� 
In addition, results vary across laboratories and depend 
on the route of exposure for induction of sensitization, 
vehicle used for skin applications, and the uses of adju-
vants and occlusion (Basketter et al�, 1993; Marzulli and 
Maguire, 1983)�
MMA testing
The results of in vivo animal testing for MMA skin sen-
sitization are presented in Table 3, which shows the test 
species, test methods for induction and elicitation of sen-
sitization, the vehicle used for induction and elicitation, 
and the test results described by the individual authors� 
In some cases, only a very few animals were included 
in testing� A number of studies reported using multiple 
methods  and  varying  vehicles,  hence  direct  compari-
sons are difficult� In general, results indicate weak sen-
sitization potential, although a significant proportion of 
studies had negative results� Negative results were more 
likely following topical applications with volatile vehicles 
(e�g�, acetone, ethanol), probably because they allowed 
the MMA test material to evaporate thereby effectively 
reducing the applied dose�
Human studies
Background
Numerous human studies have considered the adverse 
respiratory  health  effects  of  MMA  exposure,  although 
many did not specifically address the distinction between 
respiratory  irritation  and  respiratory  sensitization�  As 
detailed  below,  studies  range  from  simple  surveys  of 
self-reported complaints to descriptions of sophisticated 
physiological  and  diagnostic  testing�  The  accumulated 
literature includes epidemiological studies (cohort stud-
ies, cross-sectional studies, and mortality studies), and case 
reports of occupational asthma, occupational rhinitis and 
laryngitis, and hypersensitivity pneumonitis�
Many of the studies suffer from informational defi-
cits� As described below, studies rarely confirmed self-
reported complaints and diagnoses, whereas most relied 
on clinical and diagnostic tests that have only limited 
predictive value for asthma� Thus the clinical status of 
most of the workers described in the epidemiology stud-
ies is uncertain�
The limited adequacy of work site exposure assess-
ments  reported  in  these  studies  is  another  important 
source of uncertainty� For example, as described in epi-
demiological  studies  below,  most  workers’  exposures 
were not measured on most days and exposure levels 
were  generally  described  in  terms  of  relatively  broad 
ranges� Also, workplace exposures were almost always 
reported as long-term (i�e�, full-day) time-weighted aver-
ages; short-term peak exposures were rarely identified 
or measured� The importance of this is seen in the case 
reports, which mainly describe workers likely to have suf-
fered short-term peak exposures�
In addition, accurate measurement of airborne MMA 
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Table 3�  Summary of skin sensitization studies of MMA.
Species
Induction 
(sensitization) 
method
Elicitation (challenge)  
method Solvent Results Reference
Guinea pig maximization test
Guinea pig Intradermal  
injections (day 0);  
occlusion (day 7)
Occlusion (day 21),  
open application (day 
35)
Ind—80% ethanol;, peanut oil, 
or Aramek 
Elicit—Peanut oil or aramek
2/10 
3/10
(118)
Guinea pig Intradermal  
injections (day 0)
Ost (day 14,  
repeated up to 12 weeks)
Ind—Ethanol, FCA, saline 
Elicit—Acetone:olive oil (4:1)
0/6 (119)
Guinea pig Intradermal  
injections (3 groups),  
occlusion (1 group)
Day 21 max   non-
nonirritating  
conc. (all groups),  
24 24-h occlusion
Ind—Propylene glycol; FCA/
propylene glycol; FCA;  
petrolatum 
Elicit—Non-Nonirritating conc 
Occlusion
0/5 
2/5 
2/5 
4/5
(120)
Guinea pig Intradermal  
injections (3 rounds,  
all day 0)
Day 21, 24-h occlusion Ind— 
Group 1: FCA:distilled water 
(day 0) 
Group 2: MMA:saline (day 0)
Group 3: MMA/saline:FCA (1:1) 
(day 0) 
All groups: 24-h occlusion (day 
7) 
Elicit—Ethanol
0/10 
0/10 
0/10
(116)
Guinea pig Occlusion (days 0, 
day 7)
Occlusion Ind—(Day 0,, FCA, saline);  
(day 7, neat MMA) 
Elicit—Dilute MMA; 1%  
MMA: Vaseline,; 5% 
MMA:Vaseline (day, not 
described)
Negative (10% of  
animals treated  
with 1% conc.) 
Positive (50% of  
animals treated  
with 5% conc.)
{(121),(122)
Guinea pig Intradermal  
injections (day 0) 
OST (day 7) 
Occlusion, 48 hour 
(day 8)
Occlusion (day 21) Ind—Day 0, (FCA:Water,  
MMA: soybean oil, 
MMA:FCA:Water;) 
day 7, (MMA:Petrolatum, SDS); 
day 8, (neat MMA) 
Elicit—MMA 3%:petrolatum 
(occlusion)
9/10 (123)
Guinea pig Intradermal  
injections (day 0),  
occlusion (day 7)
24 hr Occlusion,  
24 h (day 21)
Ind— 
Group 1: (Day 0, 5% 
MMA:Water, 10% MMA:FCA.; 
day 7, neat MMA.; day 24, 5% 
MMA) 
Group 2: (Day 0, 0.15% 
MMA:water, 0.3% MMA:FCA.; 
day 7, 0.15% MMA.; day 24, 
100% MMA) 
Group 3: (Day 0, 0.001% 
MMA:water, 0.002% 
MMA:FCA.; day 7, 0.001% 
MMA.; day 24, 100% MMA) 
Group 4: (Day 0, 0.5% 
MMA:water, 10% MMA:FCA.; 
day 7, 100% MMA.; day 24, 
100% MMA) 
Elicit—Group 1: (5% MMA 
occlusion, 48 h) 
Groups 2–4: (100% MMA, 
5% MMA, acrylic particles 
occlusion, 48 h)
Group 1 (4/26) 
Group 2 (0/13) 
Group 3 (0/12) 
Group 4 (20/26)
(124)
Guinea pig Intradermal  
injections (day 0),  
occlusion (day 7)
Occlusion, 24 hr (day 14) Ind—FCA, 
MMA:dibutylphthalate, 
MMA:FCA, acetone.
Elicit—Acetone
0/10 (125)
Guinea pig Intradermal  
injections and 
topical (day 0)
Occlusion, 24 hr (day 21) Ind—Olive oil 
Elicit—Acetone
2/14 (1 M conc.) 
0/10 (10−−1 M conc.) 
0/10 (10−−2 M conc.)
(126)
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Species
Induction 
(sensitization) 
method
Elicitation (challenge) 
method Solvent Results Reference
Guinea pig Intradermal 
injections Day 0: six 6 
injections, six 6 sites, 
FCA.Day 7: SLS (24 
hr)Day 8: occlusion 
(48 hr)
Day 21, occlusion (24 hr) Ind—Olive oil:acetone (7:3)
Elicit—neat MMA
6/6 (127)
Guinea pig Intradermal 
injections, 3 control 
groups and 3 
test groups, six 6 
injections (day 0),  
SLS (day 6), 
occlusion (day 7, 
48 hr)
Occlusion (days 20, Day 
27;  
28 hr, 48 hr, 72 hr)
Ind (test groups)— 
FCA:water (1:1),  
MMA:FCA (1%, 3%, 10% MMA)
Challenge (day 20): 
1/4 (after 24, 48, 72 hr) 
2/5 (after 24, 48, 72 hr) 
5/5 (after 24, 48, 72 hr)
Rechallenge: 
1/4 (after 24, 48, 72 hr) 
1/5 (after 24, 72 hr and 
0/5 after 48 hr) 
5/5 (after 24, 72 hr and 
3/5 after 48 hr)
(128)
Guinea pig Intradermal 
injections Day 0: six 
6 injectionsDay 7: 
occlusion (Day 7, 
48 hr)
Occlusion (day 14, 24 
hr); OST (day 28)
Ind—FCA:Water (1:1), MMA 
10%:maize oil, MMA 10%:FCA/
water (1:1) 
Elicit —25% MMA; maize oil or 
maize oil/DMSO (day 14) then 
occlusion (24 hr),  
OST with 25 and 50%  
MMA in ethanol/40%  
DMSO (day 28).
5/5 
5/5 
5/5 
5/5
(129)
Beuhler
Guinea pig Method A: OST (days 
0, 2, 4, 7, 9, 11) 
Method B: OST (days 
0, 1, 2, 3, 4, 7, 8, 9, 
10, 11)
Method A: OST shaved 
flank (day 28, repeated 
up to 12 weeks)Method 
B: OST shaved neck (day 
21, repeated up to 12 
weeks)
Method A: Ethanol 
95%:2-methoxyethaol: Tween 
80 (9:9:2) 
Method B: Acetone: 
olive oil (1:1)
Method A: 0/6 
Method B: 0/6
(119)
Guinea pig OST, 6- hour 
occlusion (days 0, 
7, 14)
24- hour occlusion, day 
28
Ind—neat MMA 
Elicit —Ethanol
0/30 (116)
Freund’s complete adjuvant test (FCAT)
Guinea pig Intradermal 
injections in 
shoulder (days 0, 2, 
4, 7, 9)
Occlusion (day 21),);  
OST (Day 35)
Ind—FCA 
Elicit—Peanut oil or  
Aramek (occlusion day 21); 
peanut oil or  
Aramek (day 35, OST)
2/8 (118)
Guinea pig Intradermal 
injections multi-site 
(day 0)
Occlusion (day 14, 24 
hr);  
OST (day 28)
Ind—1 M MMA:FCA/saline 
Elicit—2.5 M in maize oil 
(occlusion); 2.5 M in DMSO/
maize oil (occlusion); 2.5 M in 
ethanol (OST); 5 M in ethanol 
(OST)
5/55/54/55/5 (129) *
Split adjuvant test
Guinea pig Multi-Site 
intradermal 
injections of dorsal 
shaved flank (day 0: 
FCA, day 1: MMA)
OST (day 14, repeated up 
to 12 weeks)
Ind—Ethanol:saline (1:100)
Elicit—Acetone:olive oil (4:1)
0/6 (119)
Guinea pig Frozen (dry Ice 
contact, day 0), 
occlusion (days 0, 
3, 4, 7), intradermal 
injections (day 4)
Day 22, 24-h occlusion Ind—Dry ice, ethanol, 
FCA:ethanol:MMA, ethanol 
Elicit—Ethanol
0/30 (116)
Polak
Guinea pig Footpad injections 
and intradermal 
injections
OST (day 7, repeated 
up to  
12 weeks)
Ind—Ethanol:saline (1:4)
Elicit—Acetone:olive oil (4:1)
0/6 (119)
Table 3� Continued.
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underestimation of exposure levels and that have often 
been ignored� Finally, the exposure of most workers was 
described for MMA, but many of those workers were also 
exposed  to  airborne  mixtures,  including  cross-reacting 
compounds  and  other  respiratory  sensitizers  and  irri-
tants� The following two sections consider the technical 
challenges for MMA measurements and the likely signifi-
cance of mixtures�
Exposure measurements: Technical challenges
Recently, concerns have been raised that the methods 
used for assessing exposures reported in epidemiologi-
cal studies and case reports may significantly understate 
actual exposure levels (Ungers et al�, 2007; Ungers and 
Vendrely, 2006)� One concern is the propensity of MMA 
to  rapidly  polymerize  on  sampling  media,  thus  form-
ing  unrecoverable  polymer�  Most  historical  sampling 
Species
Induction 
(sensitization) 
method
Elicitation (challenge) 
method Solvent Results Reference
Guinea pig Footpad injections 
and intradermal 
injections (nape of 
neck)
Group 1: OST (day 0, 
reactions recorded days 
2, 4, 5, 6) 
Group 2: OST (cross- 
reactivity) days 7, Day 14
Ind—Ethanol:saline (1:4) in 
FCA occluded,  
some also injected. 
Elicit—Acetone: 
olive oil (4:1)
0/5 (8 groups) (130)
Guinea pig 6 groups: 2 hind 
footpad injections 
each group (day 0),); 
group 1 occlusion 
day 0), groups 2–3 
occlusion (day 10), 
groups 4–5 occlusion 
(day 25), group 6 
intradermal injection 
(day 25).
Groups 1–3, OST (day 
35).); groups 4-6, OST 
(day 60)
Ind—FCA (groups 1–6) olive oil 
(groups 1, 3, 5); ethanol (groups 
2, 4); saline injection (group 6) 
Elicit—Olive oil (groups 1–3, 
day 35); olive oil (groups 4–6, 
day 60)
Group 1 (0/10) 
Group 2 (0/5) 
Group 3 (0/5) 
Group 4 (0/5) 
Group 5 (0/5) 
Group 6 (0/5)
(131)
Guinea pig Part A:6 groups: 
Footpad injections 
in each group 
(day 0).); OST, (all 
groups, days 0, 2, 5); 
group 4, additional 
intradermal injection 
(day 0); group 5, OST 
(day 25); group 6 
intradermal injection 
(day 25).Part 
B:Group 4, (same 
as above);group 7, 
(footpad injection 
(day 0), intradermal 
injection (day 0)
OST (groups 1–3, day 35),  
OST (groups 4–6, day 60)
Ind—FCA (all groups), ethanol 
(groups 1–5), saline (groups 4 
and 6) 
Elicit—Ethanol (groups 1–4), 
olive oil (groups 5 and 6)
Part A: 
Group 1 (0/25, 72 hr)
Group 2 (0/24, 72 hr)
Group 3 (0/25, 72 hr)
Group 4 (0/10, 72 hr)
Group 5 (13/13, 72 hr)
Group 6 (8/8, 72 hr) 
Part B: 
Group 4 (1/10, 48 hr)
Group 7 (2/10, 48 hr)
(132)
Draize
Guinea pig 10 intradermal 
injections over 1 
week.
Intradermal injection 14 
days after last induction 
injection  
(24-hour determination)
Ind—Saline 
Elicit—Ethanol
2/30 (116)
Mouse ear sensitization test (MEST)
Mouse Intradermal 
injection (day 0), 
topical application 
(days 0–3)
Topical application to 
ear (day 10)
Ind—FCA, Ethanol 
Elicit—Ethanol
44% sensitized, 
118% increase in ear 
thickness
(115)
Mouse Topical application 
(days 0, 2)
Topical application (day 
9)
Ind—Ethanol 
Elicit—Ethanol
114% increase in ear 
thickness (24 hours 
after challenge, p < 0.01)
(133)
Note. Ind = vehicle used for the “Induction (Sensitization)” procedure.;
Elicit = vehicle used for the “Elicitation (Challenge)” procedure.;
FCA = Freund’s complete adjuvant;
OST = open skin testing;
SLS = sodium lauryl sulfate;
SDS = sodium dodecyl sulfate.
* = Modified FCAT method.
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methods did not utilize inhibitors or store samples on dry 
ice, as is currently recommended (NIOSH, 2003; OSHA, 
2010)�  Another  concern  is  the  relative  insensitivity  of 
analytical methods; deviations from standard sampling 
and analytical protocols (e�g�, NIOSH, 2003; OSHA, 2010) 
were often required to detect and quantify short-term 
(e�g�,  15-minute)  exposures�  For  example,  higher  than 
recommended air flow rates, used in order to achieve 
lower  than  standard  levels  of  detection,  can  result  in 
sample breakthrough, MMA loss, and underestimation 
of exposure�
Such  exposure  assessment  concerns  have  special 
importance for the interpretation of specific inhalation 
challenge (SIC) testing as described in case reports� SIC 
was performed as workplace simulations for 20 (Lozewicz 
et al�, 1985) or 30 (Savonius et al�, 1993) minutes, but actual 
exposure levels were described in only one report� In that 
study, MMA exposure was monitored with an infrared 
gas analyzer; MMA levels reached 374 ppm 2 minutes 
after Palacos® R bone cement was mixed (Pickering et al�, 
1986), but levels were not described over the duration of 
the test� More recent studies have found that MMA levels 
continue to increase for 10–20 minutes after mixing bone 
cement,  reaching  levels  >1000 ppm  above  the  mixing 
bowel if emission controls are not employed� Such high 
peak  levels  are  illustrated  in  Figure  2,  which  presents 
previously unpublished data from studies by Ungers and 
colleagues (Ungers and Vendrely, 2006), who performed 
workplace  simulations  using  three  different  MMA-
containing  bone  cements�  For  each  cement,  samples 
were obtained about every 45 seconds over 20 minutes 
using  a  photo-acoustic  spectrophotometer�  Thus,  SIC 
workplace simulations may expose SIC test subjects to 
MMA peak levels nearly 15 times current occupational 
exposure limits�
Mixtures and cross-reactivity
The epidemiological studies and case reports described 
below are limited by uncertainties regarding the expo-
sures  of  concern�  This  is  of  particular  importance  for 
those  case  reports  that  performed  specific  inhalation 
challenge (SIC) without independently determining the 
composition  of  the  test  material�  The  problem  is  that 
methacrylate-containing  materials  are  almost  always 
mixtures of methacrylates and acrylates, which contain 
inhibitors, activators, and other reactive compounds that 
are known sensitizers and irritants�
These concerns have been best documented for den-
tal materials� Vankerckhoven et al� (Vankerckhoven et al�, 
1981) used HPLC, GC, and NMR to characterize the com-
position of dental resins and bonding agents and detected 
numerous  non-MMA  methacrylates�  Rustemeyer  and 
Frosch determined that dental product Material Safety 
Data Sheet (MSDS) often lacked details about the vari-
ous acrylates, methacrylates, and additives included in 
dental  materials,  often  because  manufacturers  viewed 
such  details  as  trade  secrets  (Rustemeyer  and  Frosch, 
1996)� In studies at the Finnish Institute of Occupational 
Health, Kanerva and colleagues used GC-MS to analyze 
the composition of acrylate-containing dental products 
and  to  determine  acrylate  air  levels  in  dental  clinics� 
Most analyzed products contained acrylates and meth-
acrylates known to be sensitizers that were not declared 
on MSDS (Henriks-Eckerman and Kanerva, 1997)�
The methacrylates found most often in dental resins 
and bonding materials were 2-hydroxyethylmethacrylate 
(2-HEMA),  2,2-bis[4-2-hydroxy-3-methacrylopropoxy)
phenyl]propane  (bis-GMA),  and  triethyleneglycol 
dimethacrylate (TREGDMA) (Henriks-Eckerman et al�, 
2004)�  Kanerva  et  al�  (Kanerva  et  al�,  1994;  Kanerva 
et al�, 1997) reported that TREGDMA and ethyleneglycol 
dimethacrylate comprised up to 37% of product weight 
in some dental preparations� Yoshii (Yoshii, 1997) evalu-
ated “thirty-nine acrylates and methacrylates that had 
been used in dental resin materials,” but the basis for his 
identifying them was not described� Another perspec-
tive is provided by air monitoring studies in six dental 
clinics that utilized high sampling rates (300 ml/min) to 
achieve low detection limits (0�5 μg/m3)� All six clinics 
had measurable levels of 2-HEMA and TREGDMA, but 
MMA was “not detected” in all of the clinics (Henriks-
Eckerman et al�, 2001)�
Dental materials also contain nonacrylate additives 
that are often not listed on MSDS and product labels� 
Examples include reaction initiators (e�g�, benzoyl per-
oxide),  reaction  activators  (e�g�,  tertiary  amines  such 
as  N,N-dimethyl-p-toluidine  4-tolyl  diethanolamine), 
cross-linking  agents  (e�g�,  formaldehyde),  reaction 
inhibitors  (e�g�,  hydroquinone  and  p-methoxyphenol), 
and resin carriers (e�g�, N-ethyl-4-toluene sulfonamide) 
(Kanerva et al�, 1989, 1997; Van Der Walle et al�, 1982a)� 
All of these additives are known contact sensitizers and 
several are known or suspected respiratory sensitizers 
and/or respiratory irritants (Enoch et al�, 2009; Geurtsen, 
2000; Kanerva et al�, 1997; Van Der Walle et al�, 1982a)� 
In addition, contaminants and impurities (e�g�, diglyci-
dyl ether of bisphenol A) have been associated in case 
reports with respiratory sensitization and OA (Kanerva 
et al�, 1991, 2000)�
In some studies, researchers failed to list all known 
sensitizing  components  in  the  materials  of  concern� 
For  example,  responding  to  inquiries  by  an  ECETOC 
task  force  about  the  cases  reported  in  dental  workers 
(Savonius et al�, 1993;), the authors acknowledged that 
“workers had been exposed to other acrylates than methyl 
methacrylate,” that the material used in SIC testing was 
“impure,” and that subsequent analysis determined that 
dental materials “contain many additional acrylates that 
have not been decleared [sic] in the MSDS��� additives 
and additional impurities” (Kanerva, 1993)�
Similar mixture issues pertain to bone cements and 
cosmetic  products,  but  they  have  been  less  system-
atically  studied  (Thomas  et  al�,  2008)�  Granchi  et  al� 
described differing compositions of 10 bone cements, 
but they relied on manufacturers’ declarations rather 
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et  al�,  2002)�  All  10  contained  benzoyl  peroxide  and 
N,N-dimethyl-p-toluidine, whereas 9 contained hydro-
quinone� Some contained acrylates other than MMA, 
such as butyl methacrylate (BMA) and methyl acrylate� 
In  addition,  some  bone  cements  contain  antibiot-
ics  at  levels  up  to  10%  by  weight  (“antibiotic-loaded 
cement”) (Jiranek, 2005; Jiranek et al�, 2006)� For exam-
ple,  Palacos®  R  and  CMW®  contain  gentamicin  and 
Simplex® P contains tobramycin (Connolly et al�, 2007; 
Schulze and Wollina, 2003), antibiotics that cause IgE-
mediated allergic reactions (Connolly et al�, 2007; Hall, 
1977;  Nikolaizik  et  al�,  2002;  Schretlen-Doherty  and 
Troutman, 1995; Schulze and Wollina, 2003)� Likewise, 
GC-MS  analysis  of  the  resins  and  bonding  agents 
used by an affected cosmetic nail stylist identified 11 
different  methacrylates  (Sauni  et  al�,  2008)�  The  two 
most abundant were HEMA (8%) and bis-GMA (42%), 
whereas MMA represented <0�05%�
Because  most  test  compounds  were  mixtures  of 
known sensitizers, the results of SIC using those com-
pounds can indicate that patients suffered OA or occu-
pational  rhinitis,  but  they  cannot  identify  the  causal 
agent in the mixture� A further complication is that many 
of  the  agents  cross-react,  raising  uncertainty  about 
which agent was responsible for induction of hypersen-
sitivity� Such cross-reactivity has been demonstrated in 
animals and humans using skin test protocols� In guinea 
pigs, cross-sensitization has been shown between MMA 
and  the  following  acrylates  and  methacrylates:  ethyl 
methacrylate (EMA) and BMA (Chung and Giles, 1977); 
2-HEMA, 2-hydroxypropyl methacrylate (2-HPMA), and 
ethyleneglycol  dimethacrylate  (EGDMA)  (Rustemeyer 
et  al�,  1998);  and,  EMA,  BMA,  ethyl  acrylate,  n-butyl 
acrylate,  and  neopentyl  acrylate  (Van  Der  Walle  and 
Bensink, 1982)� In addition, concomitant sensitization 
to  reaction  inhibitors  (hydroquinone  and  p-methoxy-
phenol) occurred with 7 of 11 methacrylates reported 
to be otherwise >99% pure; levels of those inhibitors in 
the methacrylate mixtures were not reported (Van Der 
Walle et al�, 1982a)� Based on frequency of positive tests 
and capacity to induce broad cross-reactivity in guinea 
pigs, Rustemeyer et al� judged 2-HEMA to be the “the 
most clinically relevant methacrylate contact sensitizer” 
(Rustemeyer et al�, 1998)�
Human patch testing with methacrylates have dem-
onstrated apparent cross-reactivity� Goon et al� reported 
patch test results in 1632 patients, of whom 48 had posi-
tive results to one or more methacrylates (Goon et al�, 
2006)� Positive responses were most frequent for 2-HEMA 
(47/48, 98%)� Of those positive for 2-HEMA, responses 
were also noted to EGDMA in 63% (30/47), TREGDMA in 
27% (13/47), and MMA in 23% (11/47)� Of the 11 patients 
who responded to MMA, all responded to 2-HEMA, 10 
responded to EGDMA, 9 responded to TREGDMA, and 6 
responded to 1,4-butanediol dimethacrylate� Rustemeyer 
and Frosch (Rustemeyer and Frosch, 1996) performed 
patch testing in 35 dental technicians with allergic con-
tact  dermatitis  and  found  that  multiple  methacrylate 
sensitizations were common� Positive results were most 
frequent  for  2-HEMA  (18/35,  51%),  EGDMA  (15/35, 
43%), and MMA (9/35, 26%)� Of 16 patients with multiple 
sensitivity, all responded to 2-HEMA, 14 responded to 
EGDMA, and 7 responded to MMA� Roche et al� (Roche 
et al�, 2008) studied 15 women with contact sensitization 
caused by acrylic fingernails� All 15 patients responded to 
at least two, and in some cases up to eight, acrylates and 
methacrylates�
Epidemiological studies
The epidemiological studies summarized below aimed to 
determine whether MMA-exposed workers had increased 
rates of respiratory symptoms, respiratory dysfunction, 
or histories of upper and lower respiratory tract diseases, 
e�g�, rhinitis, bronchitis, and asthma� Most did not verify 
self-reported diagnoses and, as described below, none 
could determine whether noted effects were specifically 
due to sensitization or irritation� Moreover, as discussed 
earlier, it can be clinically difficult to determine that an 
individual  suffers  sensitizer-  versus  irritant-induced 
respiratory disease�
There are several other sources of uncertainty in these 
studies� One source is the inherent limitation of question-
naire information, such as subjective symptoms and self-
reported diagnoses, which are generally not amenable to 
validation� None of the studies described below included 
reviews of medical records or external evidence of MMA-
related disease� Another source of uncertainty is the lim-
ited adequacy of work site exposure assessments� Most 
industrial workers are exposed to mixtures, but reported 
exposure assessments generally considered only MMA� 
In addition, the actual exposures of most workers were 
not measured on most days, thus exposure levels were 
described in terms of relatively broad ranges; short-term 
peak exposures were rarely identified�
A third source of uncertainty derives from the diag-
nostic  tests  commonly  used  in  work  site  screening 
for respiratory diseases such as asthma� Tests such as 
spirometry and peak expiratory flow rates (PEFRs) have 
only  limited  predictive  value  for  asthma,  especially 
when performed in nonstandard ways (Bernstein et al�, 
2006a; Burge et al�, 2006; Nicholson et al�, 2005; Tarlo 
et al�, 2008)� For example, a single spirometry determi-
nation of FEV1 (forced expiratory volume in one second) 
is  recognized  to  have  very  limited  diagnostic  value, 
whereas cross-shift spirometry is “insensitive” (Balmes, 
1991;  Bernstein  et  al�,  2006a;  Burge,  1982;  Nicholson 
et al�, 2005)� PEFR has only somewhat greater sensitivity 
and specificity than serial spirometry� A recent meta-
analysis  that  evaluated  PEFR  versus  specific  inhala-
tion challenge (SIC) reported pooled sensitivity of only 
56�2% (95% confidence interval [CI]: 17�2–88�8%) and 
pooled specificity of only 77�2% (95% CI: 66�5–85�2%) 
(Beach et al�, 2005)� Moreover, PEFR results depend on 
a patient’s effort and integrity because testing is usually 
unsupervised  (Hankinson,  2000;  Leroyer  et  al�,  1998; 
Perrin et al�, 1992)�Methyl methacrylate and respiratory sensitization  249
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Cohort studies
Acrylic sheet manufacture�  Pausch et al� (Pausch et al�, 
1994) conducted semiannual examinations over a 2-year 
period  (1991–1993)  in  211  male  German  acrylic  sheet 
workers (mean age 37 years) engaged in the production 
of acrylic sheets for an average of 8�8 years (range: <1 to 
>20)� Personal air samples for MMA were used to esti-
mate current exposure levels in four different work areas 
(8-hour time-weighted averages [TWAs] of 3–10, 10–20, 
20–30,  and  30–40 ppm);  however,  historical  exposures 
were  noted  to  have  been  “considerably  higher�”  Short-
term peak concentrations (100–680 ppm) were observed 
on occasion in all areas� Exclusion/inclusion criteria were 
not reported� A group of 55 recently hired workers (mean 
age  32  years)  without  previous  exposure  to  MMA  was 
characterized as a comparison group, but their outcomes 
were not reported�
Examination included a self-administered question-
naire that emphasized complaints related to nose and 
throat, but also included questions about the respiratory 
system, “asthmatic reactions,” and allergic skin reactions� 
Physical examination was limited to speculum-guided 
anterior rhinoscopy� Symptoms were considered unre-
lated  to  MMA  if  nonwork  causes  could  be  identified 
(e�g�,  hay  fever,  deviated  nasal  septum)  if  symptoms 
existed prior to MMA exposure, or if symptoms occurred 
at  home�  Among  workers  with  the  highest  exposures 
(30–40 ppm; n = 56), none of the reported nasal symp-
toms  (e�g�,  “impaired  nose  breathing,”  “dry  nose,”  and 
“rhinitis”) were related to MMA exposure� Among work-
ers in lower exposure categories, the prevalence of MMA-
related nasal symptoms ranged from 1% to 10%; effects 
were described as transient and associated with high-
peak exposures (100–680 ppm of 5–15 minutes duration)� 
A “reduced sense of smell” was reported by 4 workers 
(2/128 at 10–20 ppm and 2/20 at 20–30 ppm); 2 of those 
workers (1 case from each exposure group) were active 
smokers�  MMA-related  “eye  irritation”  (burning,  itch-
ing, or lacrimation) was reported in 3 workers (2/128 at 
10–20 ppm and 1/20 at 20–30 ppm)� Reports of “chronic 
bronchitis” were limited to 2 workers with low-level MMA 
exposures  (1/7  at  3–10 ppm  and  1/128  at  10–20 ppm) 
and exposure durations of 3 and 36 years� There were 
no reports of skin or respiratory sensitization associated 
with MMA exposure and examination found no clinical 
evidence of effects on the nasal epithelium�
This report provided evidence of reversible irritation 
to the eyes, nose, and upper respiratory tract associated 
with short-term MMA peaks >100 ppm, but no evidence 
for respiratory sensitization in workers with long-term 
moderate  to  high-level  MMA  exposures�  The  strength 
of  these  findings  is  limited  by  their  subjective  nature 
(self-reported “asthmatic reactions”)� Because all work-
ers were rotated through different areas, and potentially 
exposed to high peaks, it is also difficult to draw conclu-
sions regarding the role of exposure levels and dose�
Cross-sectional studies
Acrylic sheet manufacture�  Cromer (Cromer, 1976) con-
ducted a NIOSH study (not peer reviewed) that involved 
the screening of 91 male volunteer workers for poten-
tial  health  effects  associated  with  MMA  exposure  dur-
ing acrylic sheet production at five different US plants� 
Workers at one plant were also exposed to ethyl acrylate 
(8-hour TWA of 0�5–2�0 ppm)� Duration of employment 
was not reported� Inclusion and exclusion criteria were 
not defined, but two workers with previous welding expo-
sure were excluded� Personal sampling data were used to 
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calculate mean 8-hour TWA exposures by job category 
and  workers  were  divided  into  four  exposure  groups: 
Group  1:  <5 ppm  or  2  months  duration;  n = 13,  mean 
age 41�5 years, 39% smokers; Group 2: 5–25 ppm; n = 20, 
mean age 40�3 years, 45% smokers; Group 3: 25–50 ppm; 
n = 33, mean age 35�3 years, 70% smokers; Group 4: “not 
currently exposed,” but previous exposure >1 year; n = 25, 
mean age 51 years, 48% smokers� Group outcomes were 
compared to findings in 43 nonexposed control workers 
(mean age 45 years) employed by the same company, 
but worked in different buildings� “Controls” were signifi-
cantly older than Group 3 workers, (p < �001), significantly 
younger than Group 4 workers (p = �025), and had signifi-
cantly lower prevalence of smokers than Group 2 workers 
(p <�04)�
Workers  were  given  a  self-administered  question-
naire regarding work history, and medical history and 
respiratory  symptoms  (cough,  phlegm,  breathlessness, 
wheezing);  symptom  prevalence  and  exposed  versus 
control group differences were reported for only selected 
symptoms� In currently exposed workers, the prevalence 
of “cough” decreased with increasing exposure (23% at 
<5 ppm, 20% at 5–25 ppm, and 15% at 25–50 ppm), but 
it was lower in workers “not currently exposed” (12%) 
and lowest in controls (7%)� Significant differences were 
only observed between the lowest exposed workers (23% 
at <5 ppm) versus controls (7%) (p <�03)� Prevalence of 
sputum production was not dose related, ranging from 
23% at <5 ppm, to 50% at 5–25 ppm, to 21% at 25–50 ppm 
in  currently  exposed  groups,  32%  in  “not  currently 
exposed,” and 14% in controls� The highest prevalence of 
cough and sputum production was noted in the groups 
that had the highest prevalence of smokers, 62% in the 
lowest exposure group and 70% in the medium exposure 
group�  Outcomes  for  symptoms  of  breathlessness  and 
wheezing were not reported� No significant differences in 
the self-reported prevalence of skin or allergic problems 
were noted between the exposed and control groups�
Spirometry was performed at one time point and find-
ings were compared to a normative data base (Kory et al�, 
1961; Lapp et al�, 1974)� Differences between exposed and 
control groups in predicted-minus-observed values were 
evaluated using Student’s t test; outcomes for smokers 
and nonsmokers were analyzed separately� There were 
no significant differences in spirometry results� Among 
the  exposed  workers,  spirometry  results  were  better 
than predicted except for MMF, and were the same or 
better than the results for control workers� There were 
no significant differences in spirometry when nonsmok-
ing  exposed  workers  were  compared  to  nonsmoking 
controls�
Findings of this study are limited by the performance 
of only a single spirometry and the small size of compari-
son groups�
Monroe (1981), in an unpublished report, described 
findings of a respiratory health survey of 780 employees 
at a US Plexiglas® manufacturing facility� The study was 
undertaken  because  earlier  clinical  observations  had 
suggested an increased prevalence of pulmonary disease� 
The study group represented 94�4% of eligible workers; 
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reasons for nonparticipation included vacation, absence 
from work, and missed appointments� MMA exposures 
varied across job functions and over time� Before 1976, 
TWA and short-term exposure levels (STELs) ranged up 
to 89�9 and 134 ppm, respectively� By 1979, TWA levels 
were <50 ppm, but STELs up to 125 ppm were observed 
in  two  operations�  Workers  were  also  exposed  to  two 
other respiratory irritants, ethyl acrylate and formalde-
hyde, but at levels below their respective occupational 
exposure limits�
Evaluations included a self-administered respiratory 
questionnaire,  chest  X-ray,  and  spirometry  performed 
once  according  to  1978  American  Thoracic  Society 
(ATS) standards (ATS, 1979)� Workers were divided into 
three groups: Group 1: MMA-exposed workers (n = 68, 
mean age 38�6 years, work duration 12�1 years); Group 
2: mechanics (n = 80, mean age 47�4 years, work dura-
tion 22�3 years); and Group 3: control group consisting 
of  all  other  employees  (n = 632,  mean  age  43�5  years, 
work duration 17�3 years)� The study considered gender, 
work duration, and smoking history (current, ex-, “other” 
pipe/cigar smokers, and never) and intensity (number of 
cigarettes/day, lifetime cigarette consumption)�
Spirometry results were compared to a “normal popu-
lation” (Morris et al�, 1971) and across groups� None of 
the MMA-exposed workers had “abnormal” spirometry 
(“abnormal” defined as <70% of predicted)� Group 1 did 
not differ from the other groups, except that the never-
smoking MMA-exposed workers had significantly lower 
FEV1 than never-smoking control workers (p <�005)� The 
prevalence of less-than-predicted spirometry results was 
greater among current-smokers than other smokers and 
never-smokers (p <�025)� Chronic bronchitis was reported 
by 3 of 68 MMA-exposed workers (4%), 87 of 632 control 
workers (14%), and 12 of 80 mechanics (15%); prevalence 
was significantly lower in Group 1 (p <�026)�
The significance of these study findings is limited by 
the use of only a single spirometry and the fact that the 
MMA-exposed workers included significantly fewer and 
less intensive smokers than the mechanics and control 
workers�
Della Torre et al� (Della Torre et al�, 1982) investigated 
the potential health effects of MMA in 18 Italian work-
ers  involved  in  the  manufacture  of  Plexiglas®  sheets� 
Job-exposure  data  divided  workers  into  two  groups 
based on mean exposure levels: Group A was exposed to 
>100 ppm and Group B was exposed to <100 ppm MMA� 
Concentrations of MMA ranged from 115�4 to 180 ppm 
in  Group  A  (n = 8,  4  females,  4  males;  mean  age  35�2 
years, duration of exposure 14 years) and 4�8–83�5 ppm in 
Group B (n = 10, 4 females, 6 males; mean age 36�6 years, 
duration of exposure 10 years)�
The  prevalence  of  self-reported  symptoms  of  eye 
and throat irritation was assessed by questionnaire and 
compared to clinical examination findings� The number 
of workers who complained of “eye irritation” (Group A: 
87�5%, Group B: 20%) greatly exceeded the number of 
workers with clinical evidence of eye irritation (Group 
A: 37�5%, Group B: 10%)� Similarly, symptoms of “throat 
irritation” were reported by 62�5% of Group A workers, 
but clinical signs of throat irritation were observed in 
only 37�5%�
The  prevalence  of  episodic  “productive  cough”  was 
greater in Group A (50%) compared to Group B (20%), as 
was prevalence of frequent “productive cough” (Group 
A: 25%, Group B: 10%)� Three workers had been previ-
ously diagnosed with chronic bronchitis: one had also 
undergone laryngectomy (details not provided), a sec-
ond was a heavy smoker, and the third had been exposed 
to combustion products during maintenance of a boiler� 
Spirometry revealed no functional deficits in any of the 
workers; details were not reported�
The findings of this study are limited by the lack of a 
concurrent nonexposed comparison group and the small 
sample size�
Mizunuma et al� (Mizunuma et al�, 1993) investigated 
potential  methods  for  biological  monitoring  of  MMA 
exposure  and  also  briefly  reported  on  the  prevalence 
of subjective complaints in 32 Japanese workers (mean 
age: 43�3 years, range 21–60 years) exposed to MMA dur-
ing the production of MMA polymer (pMMA) sheets� 
Average exposure levels, determined from personal sam-
plers (carbon cloth) worn at chest level for full 8-hour 
shifts, ranged from 0�4 to 112�3 ppm (geometric mean 
[geometric  standard  deviation],  GM  [GSD]:  6�1 ppm 
[4�5]);  4  workers  experienced  levels  >50 ppm,  one  of 
which  exceeded  100 ppm�  Workers  were  divided  into 
two exposure subgroups: “high” (median 18 ppm, range 
5–112 ppm,  n = 16)  and  “low”  (median  1 ppm;  range 
<5 ppm, n = 16); duration of exposure was not reported� 
Results were compared to a group of 16 apparently non-
exposed clerical workers (mean age: 37�8 years, range 
22–60 years)�
MMA-exposed workers reported a significantly greater 
prevalence of “frequent cough and sputa” (6/32, 19%) 
and “throat irritation” (4/32, 13%); none of the controls 
complained  of  such  symptoms�  Symptom  prevalence 
appeared  dose  related:  four  of  six  cases  of  “frequent 
cough and sputa” and all four workers reporting “throat 
irritation” were from the high-exposure group�
This study failed to consider the effects of smoking and 
exposures to other workplace irritants; duration of expo-
sure was not described; there was no attempt to validate 
the subjective complaints; and the control group was of 
uncertain comparability to the exposed workers�
Pickering  et  al�  (Pickering  et  al�,  1993)  investigated 
the  prevalence  of  occupational  asthma  attributable  to 
MMA exposure in 384 of a total 431 workers (380 male; 
mean age: 37 years) employed in three English acrylic 
sheet–producing factories� Reasons for nonparticipation 
included refusals, vacations, and “unavailable�” Individual 
exposures were estimated using a job-exposure matrix 
and industrial hygiene data that included area, but not 
personal  samples�  Based  on  estimated  8-hour  TWA 
exposures, workers were categorized into three groups: 
low-exposure  (“<1  ppm”;  n = 157),  medium-exposure 252  J. Borak et al.
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(“5 ppm”; n = 163), and high-exposure (“20 ppm”; n = 64)� 
The  authors  did  not  explain  whether  these  exposure 
levels  represented  means,  medians,  or  upper  bounds� 
Doubts  about  the  exposure  scheme  were  raised  in  a 
Health  and  Safety  Executive  (HSE)  criteria  document, 
which reported that the “arithmetic mean exposure was 
approximately 22 ppm” and that “a significant proportion 
of workers would have been exposed to average concen-
trations of approximately 50 ppm” (Cary, 1995)�
Examinations  included  an  administered  respiratory 
questionnaire and spirometry� Spirometry readings were 
performed in 380/384 and findings were compared to 
a  normative  database�  Symptoms  (persistent  cough, 
chronic bronchitis, chest tightness, wheeze, and breath-
lessness)  were  considered  work  related  if  they  were 
reported to be exacerbated during a work shift, or if they 
improved over weekends and holidays�
The prevalence of work-related symptoms was low 
(1�0–3�4%, 7–13 individuals for each symptom), particu-
larly when compared to the prevalence of non–work-
related symptoms (4�2–9�9%; 16–38 individuals)� There 
was a significant excess of smokers (current and past) 
among workers who reported work-related symptoms 
(25 of 27; 92�6%) compared to the proportion of smok-
ers in the total study population (255 of 384; 66�4%)� 
Nine workers (2�3%) reported two or more respiratory 
symptoms, but none gave a history of work-relatedness 
consistent with OA� Transient high exposures to MMA 
were reported by 70% of workers and were associated 
with  increased  frequency  of  cough,  chest  tightness, 
shortness of breath (SOB), wheezing, and eye and nasal 
irritation� The prevalence of symptoms related to tran-
sient  high  exposures  was  significantly  greater  among 
ever-smokers than never-smokers (p <�05)� Symptoms 
were  significantly  reduced  among  workers  who  had 
never experienced transient high exposures compared 
to  those  that  had  (p  <�05)�  Stepwise  forward  logistic 
regression identified “past or present smoking history” 
as  a  significant  predictor  of  work-related  respiratory 
symptoms  (p  <�01),  whereas  the  “frequency  of  high 
exposure  incidents”  was  of  borderline  significance 
(p = �05)�
Spirometry results were compared to predicted nor-
mative values, not to a control group� In the exposed 
workers,  FEV1  was  lower  than  predicted  (95�6–97�8 
%)  and  forced  vital  capacity  (FVC)  was  higher 
(100�6–102�1%)�  Those  differences  were  statistically 
significant,  but  probably  not  clinically  significant� 
Cumulative smoking history (pack years) was the only 
parameter significantly associated with reduced FEV1 
(p <�01), and no study parameter was associated with 
FVC� Level of MMA exposure was not associated with 
lung  function  once  smoking  habits  were  accounted 
for�
The high participation rate (89% of eligible workers) 
lends strength to the study findings, but conclusions are 
limited by the use of spirometry at only one point in time, 
and the lack of a concurrent control group�
The  HSE  criteria  document  referred  to  a  follow-up 
study  that  included  former  employees,  but  we  have 
not been able to document or obtain such a study� In 
response to inquiries, one of the authors wrote: “I can’t 
remember if we did manage to get the second part done, 
we found very little as you will see from the first report” 
(Niven, 2009)�
Dental technicians�  Rajaniemi and Tola (Rajaniemi and 
Tola,  1985)  reported  the  prevalence  of  symptoms  and 
medical history in 202 Finnish dental technicians exposed 
to MMA� Principal concerns of the study were dermatitis 
and neuropathy, but respiratory effects were also consid-
ered� The dental technicians included 77 females (ages 
17–54 years) employed an average of ≥6 years (range: 
1–23 years) and 125 males (ages 17–58 years) employed 
an average of ≥8 years (range: 1–40 years)� Findings were 
compared to 91 dental students (34 females, ages 18–51 
years and 57 males, ages 15–33 years)�
Self-reported information was obtained using a mailed 
questionnaire (91% response rate): 81% (164/202) of the 
dental technicians reported handling MMA “daily with-
out skin protection,” 57% (115/202) reported handling 
MMA  for  ≥1–3  hours  per  day,  41%  (83/202)  handled 
MMA <1 hour per day, and 4 reported no MMA exposure� 
MMA exposure was not described in the students�
Asthma “diagnosed by a physician” during the pre-
vious 12 months was reported by 3�5% of technicians 
(7/202) and 1% (1/91) of students� Among technicians, 
the rates of self-reported “allergic rhinitis” (31%, 63/202) 
and “allergic conjunctivitis” (11�4%, 23/202) were more 
than  twice  the  rates  reported  by  the  students  (13%, 
12/91 and 5�5%, 5/91, respectively)� Technicians with 
self-reported “dermatitis” were significantly more likely 
to  report  “symptoms  of  allergic  rhinitis”  (26%  versus 
42%, p <�05) and “symptoms of allergic conjunctivitis” 
(7%  versus  20%,  p  <�05),  but  there  was  no  increased 
prevalence of physician-diagnosed asthma�
This study is limited by its reliance on unverified self-
reported information and lack of exposure data�
Nishiwaki et al� (Nishiwaki et al�, 2001) assessed the 
health of 19 male dental technicians (mean age: 37�8 ± 12�4 
years) routinely exposed to MMA� Time-weighted aver-
age MMA levels ranged from 0�16 to 4�38 ppm (mean: 
1�4 ppm) for an unspecified duration� Maximum MMA 
levels, measured over a 1�5-hour duration during hot-
curing of resins, ranged up to 37�7 ppm� Post-shift urine 
methanol levels averaged 4�21 mg per g creatinine (range: 
0�87–14�03), but duration of exposures was not reported1� 
Findings were compared to nine male dental technicians 
(mean age: 40�0 ± 10�1 years) who worked in the same 
laboratory, but were not exposed to MMA (confirmed via 
passive sampling)� Selection criteria were not otherwise 
specified�
1The current American Conference of Industrial Hygienists (ACGIH) 
Biological Exposure Indice (BEI) for methanol is 15 mg/L in end-of-shift 
urine (ACGIH, 2010).Methyl methacrylate and respiratory sensitization  253
© 2011 Informa Healthcare USA, Inc. 
Examinations included a self-administered question-
naire  for  symptoms,  smoking  habits,  past  and  present 
illnesses, and daily job requirements; spirometry was per-
formed once� Exposed and controls technicians were simi-
lar on all demographics, but nearly twice as many exposed 
technicians were current-smokers (57�9% versus 33�3%)� 
Compared  to  controls,  exposed  technicians  reported 
significantly  higher  prevalence  of  “cough  during  work” 
(6/19 versus 0/9, p <0�05)�That difference was no longer 
significant after stratification by smoking� Both groups had 
a similar prevalence of “phlegm during work” (5/19 versus 
2/9), which was reported only by smokers�
Spirometry was performed and evaluated according 
to  recommendations  of  the  Japan  Society  of  Thoracic 
Diseases�  Compared  to  controls,  exposed  technicians 
had significantly lower mean values of %FVC/HT 94�4% 
± 7�6% versus 105�5% ± 9�1%) and %FEV1/HT (96�8% ± 
7�2%  versus  107�2%  ±11�4)�  The  only  comparison  that 
remained significant after adjustment for smoking was 
%FVC/HT in nonsmoking exposed versus nonsmoking 
controls (92�9% ± 8�8% versus 110�0% ± 3�5%, p <�05)�
The study is limited by its small sample size, use of 
spirometry at only a single time point, higher frequency 
of smokers in the exposed group, and failure to adjust for 
exposures to dusts and metals that the authors noted to 
be present�
Other industries�  Marez et al� (Marez et al�, 1993) evalu-
ated the effects of MMA on the lung function of 40 French 
workers (mean age 37 years) exposed to MMA for >5 years 
(32 workers for >10 years)� Findings were compared to 45 
controls who had similar jobs, but had not been exposed 
to  MMA  or  other  known  respiratory  irritants�  Workers 
with  previous  occupational  exposure  to  “dusty  trades” 
(n = 81)  or  short-term,  low-level  MMA  exposures  (<5 
years at 0�7–2�7 ppm, n = 14) were excluded� The workers 
were employed at two factories (industries not described) 
where 8-hour TWA MMA concentrations were 18�5 ppm 
(range: 9–32 ppm) and 21�6 ppm (range: 11�9–38�5 ppm)� 
There were no differences in mean age, height, or weight 
between exposed and controls� Smoking rates were slightly 
higher in exposed workers (40% current-smokers, 27�5% 
ex-smokers) compared to controls (40% current-smokers, 
15�5% ex-smokers), but cumulative smoking intensity was 
lower in the exposed workers (13 versus 16 pack-years)�
An administered questionnaire elicited self-reported 
symptoms (cough, sputum production, dyspnea, wheez-
ing) and history of asthma or chronic bronchitis� None 
of the workers reported a history of asthma� Symptoms 
were more frequent in the MMA-exposed group, but the 
only significant difference was chronic cough (p = �04), 
which remained significantly elevated after adjustment 
for smoking status (p = �03)� Spirometry was performed 
twice, at the start of a work shift (“pre-shift”) and two 
hours before the end-of-shift (“post-shift”), according to 
criteria that were “stricter than” ATS recommendations 
(ATS, 1979, 1987)� Pre-shift results did not differ between 
exposed and control workers� Nearly all workers had 
a  decrease  across  the  work  shift,  which  was  greatest 
among the MMA-exposed workers; the only significant 
difference involved mid-expiratory flow rates�
A  subsequent  HSE  Criteria  Document  (Cary,  1995) 
questioned  the  validity  of  this  study’s  exposure  mea-
sures  in  light  of  reports  that  the  technique  used  was 
“inaccurate�”
Lindberg et al� (Lindberg et al�, 1991) conducted a pilot 
study for the Swedish National Institute of Occupational 
Health  to  evaluate  the  health  effects  of  chronic  high-
level exposure to MMA in 10 Swedish “floor layers” with 
mean age of 31 years (range: 20–60 years) who had been 
coating  concrete  floors  “exclusively”  with  MMA-based 
plastics for an average duration of 4�6 years (range: <1–12 
years)� The study focused on respiratory and nervous sys-
tem effects� “Portable sampling equipment” was used to 
measure MMA levels under a variety of conditions that 
varied by stage of work, room size, and ventilation condi-
tions� Daily mean concentrations of MMA varied from 62 
to 601 ppm (median: 175 ppm)�
Examinations  included  an  interview  regarding 
work-related  respiratory  symptoms,  medical  history, 
smoking,  alcohol  consumption,  and  routine  physical 
examination�  Findings  in  the  exposed  workers  were 
compared to 10 age-matched controls who had partici-
pated in an earlier project� Lung function was assessed 
using spirometry, serial PEFR measured three times per 
day  for  1  week,  methacholine  challenge,  and  carbon 
monoxide diffusing capacity (DLco)�
Workers complained of acute eye and throat irritation� 
Three (30%) reported eye irritation at least once per week 
and another three (30%) reported eye irritation at least 
one to three times per month� Three workers complained 
of throat or nose irritation� In six of the workers, physi-
cal examination revealed erythema of palate arches and 
tonsils�
Spirometry results and DLco were within or above the 
normal range� All methacholine tests were normal� PEFR 
was performed in five workers and all were “normal”; no 
explanation was provided for those who did not perform 
PEFR� Complete blood counts were performed in 9 of 
10 workers� Two had slightly elevated total white blood 
cell (WBC) counts (13�1 × 109/L and 10�3 × 109/L), a third 
had increased eosinophils (13%), a fourth had slightly 
increased monocytes (12%), and a fifth had borderline 
increased lymphocytes (46%)�
This study is limited by its small sample size�
Mortality studies
The mortality experience of MMA-exposed workers has 
been  evaluated  in  four  studies  that  considered  nine 
separate cohorts� Three of those studies specifically con-
sidered mortality rates due to asthma in seven separate 
cohorts�
Collins  et  al�  (Collins  et  al�,  1989)  evaluated  the 
mortality experience of 2671 men, of whom 1561 were 
exposed to “significant amounts of MMA” at two plants 
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Table 4�  Summary of 19 case reports.
Author Year
Occupation/exposure 
context
Diagnosis or “clinical 
description” PFT PEFR NSIC Specific inhalation challenge
Dental exposures
Lozewicz 1985 Dental Assistant: working 
on dental prosthetic trays
Asthma NR (−) NR (+) pMMA powder & MMA 
liquid 
NR: Placebo
Basker 1990 Denture wearer Asthma NR (−) NR NR (see text)
Savonius 1993 Dental Technician Asthma NR NR NR (+) Mix 10 g methacrylate 
powder & 10 ml methacrylate 
liquid 
NR: Placebo
Wittczak 1996 Dental Technician Asthma (+) NR NR (+) MMA-containing acrylics 
(Superacryl, Duracryl)(−) 
Placebo
Piirila 1998 Dental nurse Asthma (−) (+) (+) H (+) Paladur dental composite 
resin 
(−) “Scotchbond” primer 
NR: Placebo
Piriila 1998 Dentist Laryngitis (−) (−) (−) H (−) Paladur or Forestacryl 
dental composite resins 
NR: Placebo
Scherpereel 2004 Dental Technician trainee Hypersensitivity 
pneumonitis
(+) NR NR NR
Scherpereel 2004 Dental Technician trainee Hypersensitivity 
pneumonitis
(+) NR NR (+) “Aerolized” MMA particles
Thorette 2006 Dental student Hypersensitivity 
pneumonitis
NR NR NR NR
Orthopedic exposures
Lee 1984 Operating Room 
Anesthetist: bone cement
“Tightness in the chest” NR NR NR NR
Scolnick 1986 Surgical Nurse trainee: near 
bone cement mixing table
“Difficulty in breathing” NR NR NR NR
Pickering 1986 Surgical Nurse: mixing 
bone cement
Asthma (−) NR NR (+) Palacos bone cement with 
gentamicin 
NR: Placebo
Reynaud-
Gaubert
1991 Surgical Nurse: mixing 
bone cement
Asthma (−) NR (+) A (+) Palacos bone cement with 
gentamicin
Kirby 2003 Operating Room Radiology 
Technician: bone cement
Bronchospasm NR NR NR NR
Other exposures
Kennes 1981 Handyman: Plexiglass 
cutter
Asthma (+) NR NR (+) TDI varnish 
(+) Plexiglass shavings 
(−) Other (see text)
Lozewicz 1985 Railway cable joiner “Headache, sweating,  
and lassitude”
NR (+) (−) H (−) Acrylic cold curing resin 
system containing MMA 
(−) Placebo
Savonius 1993 Plate engraver Asthma NR NR (−) H (+) MMA-containing glueNR: 
Placebo
Savonius 1993 Hearing aid assembler Asthma NR NR (+) H (−) Ground piece of 
methacrylate 
NR: Placebo
Wittczak 2003 Secretary: photocopying Asthma NR NR (+) H (+) MMA, heated 
(+) Photocopy toner 
(−) Placebo
Key:Note.
PFTs: = pulmonary function tests (spirometry);
PEFR: = peak expiratory flow rates;
NSIC: = non-specific inhalation challenge;
NR: = tests were either not performed or results were not reported;
H: = histamine challenge;
A: = acetylcholine challenge;
(−): = test results were normal;
(+): test results were positive (as reported by authors).Methyl methacrylate and respiratory sensitization  255
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compared to the unexposed workers; however, the report 
indicated a total of 1971 unexposed workers, or 861 more 
than were otherwise accounted for� The authors reported 
a nonsignificant increase in mortality from “all respira-
tory disease” (standardized mortality ratio [SMR]: 2�16, 
observed = 4,  expected = 1�9,  p  >  �05)�  Asthma-related 
deaths were not reported�
Walker et al� (Walker et al�, 1991) evaluated mortality 
in three cohorts of white US male MMA manufacturing 
workers  (Early  Bristol  [EB]:  n = 3934,  1933–1986;  Later 
Bristol [LB]: n = 6548, 1946–1982; Knoxville [K]: n = 3381, 
1943–1982) as compared to white US males, adjusted for 
age  and  calendar  period�  Asthma-related  deaths  were 
less than expected overall (observed = 3, expected = 5�53) 
and SMRs were less than expected in all three cohorts 
(EB: SMR = 0�33; LB: SMR = 0�87; K: SMR = 0�73)�
Lucas (Lucas, 1995) evaluated the mortality experi-
ence of 1808 white US males exposed to MMA ≥90 days 
while  manufacturing  acrylic  sheet  during  1961–1987� 
Cause-specific morality rates were compared to rates for 
white male residents of Maine� MMA-exposed workers 
experienced lower than expected SMR for nonmalignant 
respiratory disease (“bronchitis, emphysema, asthma”) 
SMR: 63 (95% CI: 17�2–161�3) based on 4 observed versus 
6�35  expected�  Only  limited  smoking  information  was 
available�
Tomenson et al� (Tomenson et al�, 2000) evaluated the 
cause-specific mortality rates of 4324 workers (119,822 
person-years)  in  three  cohorts  of  workers  exposed  to 
MMA at two UK plants while manufacturing acrylic sheets 
during 1949–1988� There was a lower than expected mor-
tality rate for asthma (observed = 1, expected = 4�45; SMR 
not calculated)�
Case reports
Background
Unlike epidemiological studies, which largely depend on 
self-reported questionnaire data and workplace screen-
ing tests, most of the case reports and case series sum-
marized below presented detailed personal histories and 
results of specific diagnostic testing� Thus, case reports 
can provide objective bases for specific diagnoses and 
they may contain the sorts of information necessary to 
differentiate sensitizer versus irritant effects�
In  some  case  reports,  respiratory  sensitization  and 
respiratory  irritation  have  been  differentiated  on  the 
basis  of  disease  latency�  Induction  of  sensitization  is 
usually  associated  with  a  latency  of  weeks  to  months 
after first exposure; accordingly the onset of symptoms 
weeks or months after first exposure suggests sensitiza-
tion� After sensitization has occurred, however, response 
to exposures (i�e�, “elicitation”) develops within minutes 
or hours� Irritant-induced effects generally occur with-
out latency, i�e�, onset occurs immediately after a large 
initial exposure (Bernstein et al�, 2006b; Wallace et al�, 
2008)� Because it can be difficult to determine whether 
a response immediately following exposure represents 
  irritation-induced  effects  or  response  elicitation  in  a 
previously  sensitized  individual,  it  may  be  difficult  to 
decide whether a particular reaction represents sensi-
tization or irritation� Moreover, irritant-induced effects 
may  have  apparent  latency�  Initial  reports  of  irritant-
induced asthma (e�g�, reactive airway dysfunction syn-
drome) described almost immediate onset of effects after 
high-level exposure (Boulet, 1988; Brooks et al�, 1985), 
but more recent reports describe cases in which effects 
developed following repeated exposures over months or 
years (Gautrin et al�, 2006; Glindmeyer et al�, 2003; Kipen 
et al�, 1994; Tarlo and Broder, 1989)�
In addition, relatively low levels of irritants can pro-
voke typical clinical signs of asthma (e�g�, wheeze, chest 
tightness,  cough,  breathlessness)  in  individuals  with 
nonspecific bronchial hyperreactivity (NSBH) (Gautrin 
et al�, 2006; Kimber et al�, 2007)� NSBH is a characteristic 
of asthma caused by respiratory sensitization, but it is 
also found after high-level irritant exposure and as a con-
sequence of smoking and respiratory infections (Cerveri 
et al�, 1989; Crapo et al�, 2000; Empey et al�, 1976; Jensen 
et al�, 1998)� In individuals with NSBH, the clinical effects 
and latency pattern of sensitizers and irritants may be 
indistinguishable� Further confusion can result because 
some compounds, such as MMA, have both allergenic 
and irritant activities� In some cases, both mechanisms 
act  simultaneously  (Arts  et  al�,  1998;  Briatico-Vangosa 
et  al�,  1994;  Kimber  et  al�,  2007;  Pauluhn  and  Mohr, 
2005)�
Immunoglobulin E (IgE) levels have been proposed as 
a means of differentiating respiratory sensitization and 
respiratory irritation� IgE production is an important and 
perhaps essential aspect of the process leading to respi-
ratory  sensitization  (Kimber  and  Dearman,  2002)  and 
measurements of total and antigen-specific serum IgE 
levels are standard components of the clinical evalua-
tion of asthma and rhinitis (AHRQ, 2002; Bousquet et al�, 
2008; Lemiere et al�, 2006; Quillen and Feller, 2006; Tarlo 
et  al�,  2008)�  But,  unlike  HMW  respiratory  sensitizers, 
which are strongly associated with specific IgE antibody 
production,  IgE  has  not  been  consistently  associated 
with most LMW respiratory sensitizers (Bernstein et al�, 
2008; Tarlo et al�, 2008)� In a recent meta-analysis of 11 
studies that reported sensitivity and specificity for OA of 
specific IgE antibodies versus SIC, pooled sensitivity for 
LMW asthmagens was only 31�2% (95% CI: 22�9–40�8%); 
by contrast, pooled sensitivity for HMW sensitizers was 
73�7–81�7% (Beach et al�, 2005)� The pooled specificity 
for LMW asthmagens was 88�9% (95% CI: 84�7–99�2%)� 
Accordingly, antigen-specific IgE testing is “usually not 
indicated”  for  asthmatics  exposed  to  LMW  chemicals 
(Tarlo et al�, 2008)� Total serum IgE levels are said to have 
“poor predictive value” for allergic rhinitis and should not 
be used for diagnostic purposes (Dykewicz et al�, 1998; 
Ng et al�, 2000; Weed and Hursting, 1998)� Measurement 
of antigen-specific IgE has been recommended in the 
evaluation of rhinitis patients, but most reports describe 
results for only HMW sensitizers (Dykewicz et al�, 1998)� 
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antibodies to LMW sensitizers reflects alternative immu-
nological mechanisms or limitations of current analytical 
methods (Campo et al�, 2007)� Because test antigens for 
LMW sensitizers are usually prepared and evaluated in 
individual research laboratories, the antigens have not 
been standardized and results from different laboratories 
are usually not comparable (Bernstein et al�, 2008)�
Other tests used to evaluate respiratory sensitization 
include eosinophil counts in blood or sputum and skin 
prick  testing  (SPT)�  A  recent  meta-analysis  identified 
only two studies that reported the sensitivity of blood 
eosinophil  counts  for  LMW  asthmagen-induced  OA; 
pooled sensitivity was 53�1% (95% CI: 10�3–91�8%) (Beach 
et al�, 2005)� The utility of eosinophil counts in allergic 
rhinitis has not been well studied, but is likely to be low; 
eosinophil counts >5–20% have been reported in up to 
33% of patients with nonallergic rhinitis (Dykewicz et al�, 
1998; Ellis and Keith, 2006; Quillen and Feller, 2006)� SPT 
is sometimes used as a preferred, albeit indirect measure 
of IgE (Quillen and Feller, 2006; Wallace et al�, 2008)� A 
recent meta-analysis identified 16 studies of asthmatics 
that reported results of SPT for LMW asthmagens� In five 
studies reporting both the sensitivity and specificity of 
SPT versus SIC, the pooled estimate of sensitivity was 
72�9% (95% CI: 59�7–83�0%), whereas pooled estimated 
of  specificity  was  86�2%  (95%  CI:  77�4–91�9%)  (Beach 
et al�, 2005); sensitivity was lower in studies not reporting 
specificity� SPT is a widely used clinical test in the diag-
nosis of allergic rhinitis, with a sensitivity that is similar 
to that for asthma (Wallace et al�, 2008)� In this context, 
it is a standard test for HMW sensitizers, but not LMW 
asthmagens (Bernstein et al�, 2008)�
SIC is considered the “gold standard” for confirmation 
of OA (Maestrelli et al�, 2006; Tarlo et al�, 2008; Vandenplas 
et al�, 2006)� Patients are exposed to the suspected agent(s) 
in an exposure chamber or workplace simulation and 
their respiratory response determined by spirometry or 
PEFR� SIC is clinically indicated for sensitizer-induced 
asthma, but not for irritant-induced asthma (Tarlo et al�, 
2008;  Vandenplas  et  al�,  2006;  Vandenplas  and  Malo, 
1997)� The sensitivity and specificity of SIC have not been 
determined because there are no other tests to which it 
can be compared, but it is known to yield false-positive 
and false-negative results� False positives are of particu-
lar concern when the test chemical is an irritant (Beach 
et al�, 2005; Tarlo et al�, 2008; Vandenplas et al�, 2006)� 
Individuals with NSBH can have immediate bronchial 
responses during SIC, especially with irritant chemicals, 
so that responses to irritants and sensitizers cannot be 
distinguished (Briatico-Vangosa et al�, 1994; Nicholson 
et al�, 2005; Tarlo et al�, 2008; Tarlo and Broder, 1989; 
Vandenplas et al�, 2006; Vandenplas and Malo, 1997)�
A  different  concern  is  that  many  of  the  methacry-
late-containing  materials  that  have  been  used  for  SIC 
challenges are mixtures; in some cases their actual com-
positions are not known� In such cases, positive SIC can 
serve to diagnose OA, but it cannot determine the causal 
agent�
Overview
The following published case reports describe 19 indi-
viduals who were evaluated because of suspected respi-
ratory  sensitization  to  MMA  monomer  and/or  MMA 
polymer (pMMA)� They have been grouped according to 
their sources of exposure: dental exposures, orthopedic 
exposures, and other exposures (Table 4)� Clinical evalu-
ations varied across reports and descriptions of testing 
methods were often incomplete� In most reports, expo-
sures of concern were incompletely or wrongly described� 
As discussed above (see Mixtures and Cross-Reactivity), 
methacrylate-containing  dental,  orthopedic  and  other 
materials are almost always mixtures of methacrylates 
and acrylates plus inhibitors, activators, and other reac-
tive compounds that are generally incompletely identi-
fied� Some authors referred to “MMA” when they meant 
“pMMA”  or  “methacrylate-containing  copolymers�” 
Materials used for SIC were mixtures that were neither 
analyzed  not  completely  described�  Actual  workplace 
exposure levels associated with sensitization and levels 
experienced during SIC were almost never detailed�
The summaries below employ the following conven-
tions: (1) Unless noted in the summary, the composi-
tion of MMA-related materials was not described in the 
report�  For  those  reports,  the  summaries  either  pres-
ent the actual phrase used to describe the material (in 
“quotation marks”) or simply refer to MMA-containing 
material�  (2)  Unless  noted  in  the  summary,  historical 
exposures levels and exposure levels occurring during 
SIC were not described in the report� (3) Unless noted 
in  the  summary,  the  following  clinical  tests  were  not 
described in the report: (a) total IgE, (b) antigen-specific 
IgE; (c) eosinophil count; (d) SPT; (e) patch test for acry-
late sensitizers; (f) bronchoalveolar lavage (BAL)�
Dental exposures
Lozewicz et al� (Lozewicz et al�, 1985) reported seven cases 
of occupational asthma, of whom two had been exposed 
to  MMA-containing  materials�  One  of  those  patients, 
Patient 6, was a 40-year-old male dental assistant who 
had worked for several years on dental prosthetic trays 
before he experienced work-related symptoms of chest 
tightness, dyspnea, and cough that persisted for several 
hours after mixing “pMMA powder with MMA liquid�” 
He gave no history of wheeze or breathing difficulty other 
than the work-related episodes� Spirometry and nonspe-
cific inhalation challenge (NSIC) were not reported and 
PEFR away from work was normal� SIC was positive (24% 
fall in PEFR which resolved within 2 hours) after simu-
lated workplace exposure mixing “PMMA powder with 
MMA liquid” monomer for 20 minutes� Repeat testing 1 
week later resulted in a similar response� Placebo testing 
was not performed�
Basker et al� (Basker et al�, 1990) reported a 65-year-
old woman with a 12-year history of asthma, for which 
she had been hospitalized and chronically treated with 
corticosteroids� Her asthma began shortly after she was 
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attacks when exposed to cigarette smoke, petrol fumes, 
and  perfume  and  she  described  wheezing  and  skin 
reactions after contact with acrylic fabrics� Spirometry 
and NSIC were not reported, PEFR was negative� She 
also  complained  of  throat  burning,  sore  mouth,  and 
facial pain� IgE test and radioallergosorbent test (RAST) 
NOS were “normal�” Her asthma “subsided gradually” 
after she stopped wearing her dentures�
SIC  were  not  performed,  but  the  patient  was  chal-
lenged  with  dentures  made  of  three  different  base 
materials:  vulcanite;  Flexiplast  (nylon  12);  and  “clear 
heat-cured  pMMA�”  The  first  two  caused  no  adverse 
effects, but 4 hours after insertion of the pMMA denture 
she experienced a “severe asthma attack” that required 
corticosteroids�
Savonius et al� (Savonius et al�, 1993;) reported find-
ings in 3152 patients evaluated for occupational respi-
ratory  disease  (pneumoconiosis  not  included)�  MMA 
exposure was associated with 3 of 880 cases diagnosed as 
having OA/respiratory disease� One of those three was a 
dental technician�
Patient M-3 was a 46-year-old female who first devel-
oped paresthesia of the ulnar sides of both hands, but 
no dermatitis after 20 years working as a dental tech-
nician�  Subsequently  she  developed  “tickling  in  her 
throat, yawning, cough, tiredness and chest tightness�” 
Symptoms  subsided  during  vacation  and  reappeared 
within one week after return to work� SPT (“methacrylate 
and  PEGDMA”)  and  patch  tests  (acrylate  series)  were 
negative� Spirometry, PEFR, and NSIC were not reported� 
SIC was positive (PEFR fell 26%; immediate and late reac-
tion) with 30 minutes of work simulation mixing “meth-
acrylate powder” and “methacrylate liquid�”
Wittczak  et  al�  (Wittczak  et  al�,  1996)  described  a 
40-year-old female dental technician who experienced 
increasingly severe attacks of coughing and nasal secre-
tions beginning several hours after contact with MMA-
containing  materials  (“Superacryl,  Duracryl”)�  The 
attacks first began 6–8 months after she started working 
and responded to cromolyn and corticosteroids, which 
allowed her to continue working� After nearly 13 years, 
she  received  a  disability  pension  because  of  OA�  Six 
years later, she was hospitalized for respiratory distress 
after  again  working  with  MMA-containing  prosthetic 
materials� Total IgE was 107�6 kU/L, the peripheral blood 
eosinophil count was elevated (935 per mm3), SPT was 
negative  (common  allergens)  and  acrylate  patch  tests 
were negative� Spirometry was abnormal (FVC: 75% pre-
dicted, FEV1: 82% predicted)� PEFR and NSIC were not 
reported�
SIC was positive (FEV1 fell >40% at 4 hours and PEFR 
fell > 50% at 24 hours) after work simulation mixing “liq-
uid MMA” and “MMA powder” for 20 minutes� Twenty-
four hours following SIC, nasal lavage showed increased 
WBC  count  (311�6 × 103/ml)  and  increased  eosinophil 
count (54�7 × 103/ml)�
Piirila et al� (Piirila et al�, 1998) described 12 dental 
workers with evidence of “acrylate induced respiratory 
hypersensitivity�” Of the 12, only 2 had been exposed to 
MMA-containing materials�
Patient 6 was a 51-year-old female dentist with a clini-
cal diagnosis of occupational laryngitis� She had been 
exposed to acrylics for 27 years and had “symptoms” NOS 
for 23 years� Details of her work exposures to methacry-
late-containing  materials  were  not  reported�  Total  IgE 
was 17 kU/L� SPT was negative for common environmen-
tal allergens, latex, and methacrylates (MMA, 2-HEMA, 
bis-GMA, EGDMA, TREGDMA) and acrylate patch tests 
were negative� Spirometry PEFR and NSIC were normal� 
SIC was negative after workplace simulation with “pros-
thesis dose of powder” (Paladur®, Forestacryl®)�
Patient 8 was a 48-year-old female dental nurse with 
a  27-year  history  of  “mixing  dental  composite  resin 
products” that contained “various acrylates�” During the 
prior 2 years she experienced hoarseness, sore throat, 
nasal stuffiness and dyspnea, particularly when prepar-
ing orthodontal fixatives� Total IgE was increased (203 
kU/L)�  SPT  was  negative  for  common  environmental 
allergens,  latex,  and  methacrylates  (MMA,  2-HEMA, 
bis-GMA, EGDMA, TREGDMA) and acrylate patch tests 
were negative� Spirometry was normal, histamine inhala-
tion challenge testing was “slight positive” (FEV1 fell 15% 
with 0�48 mg histamine), and PEFR was positive� SIC was 
positive after workplace simulation exposure to Paladur® 
(“mucosal changes and symptoms of the upper respira-
tory  tract”;  rhinomanometry:  70%  increase  in  airflow 
resistance; FEV1 fell only 6%; PEFR fell 20% after 16 hours)� 
SIC was negative after workplace simulation exposure to 
Scotchbond® primer (2-HEMA and bis-GMA)�
Scherpereel et al� (Scherpereel et al�, 2004) reported 
two  cases  of  “hypersensitivity  pneumonitis”  in  dental 
technician trainees “within the first weeks of exposure to 
MMA” in a laboratory�
Patient 1 was a 24-year-old female who was hospital-
ized for progressive severe dyspnea and cough 6 months 
after the start of training� Physical examination revealed 
diffuse bilateral crackles, arterial blood was hypoxemic 
(Pao2:  55 mm  Hg),  DLco  was  45%  of  predicted,  and 
computed tomography (CT) scan showed ground glass 
pattern� Her symptoms responded to systemic corticos-
teroids  treatment�  One  month  later,  after  returning  to 
work for 3 days, she again required hospitalization for 
severe dyspnea� She was hypoxemic (Pao2: 58 mm Hg)� 
Spirometry  was  abnormal  (FVC:  50%  predicted;  FEV1: 
24% predicted)� BAL was abnormal (cell count: 570,000 
cells/ml; 10% macrophages, 60% lymphocytes, 25% neu-
trophils)� PEFR, NSIC, and SIC were not performed�
Patient 2 was a 20-year-old female who was hospital-
ized for acute respiratory distress a few weeks after the 
start of training� She had “major dyspnea,” cough and dif-
fuse bilateral crackles, arterial blood was hypoxemic (Pao2: 
65 mm Hg), she had “pulmonary diffusion abnormality,” 
and chest X-ray showed bilateral ground glass patterns� 
Spirometry  was  abnormal  (total  lung  capacity  [TLC]: 
67% of predicted)� PEFR and NSIC were not performed� 
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treatment� SIC was positive (“moderate dyspnea,” 20% fall 
in TLco, 20% fall in DLco, and 30% lymphocytes in bron-
choalveolar  lavage  [BAL])  after  exposure  to  “aerolized 
particles of MMA” while in a “glass cage�”
Thorette  et  al�  (Thorette  et  al�,  2006)  reported  a 
19-year-old  female  prosthetic  dentistry  student  who 
developed  hypersensitivity  pneumonitis  after  working 
with “MMA�” No other clinical details were described� CT 
scan revealed micronodules and ground glass infiltrates� 
BAL was positive BAL BAL was positive  (“hypercellular-
ity,”  >50%  lymphocytes)  and  “���alveolar  macrophages 
filled  with  methacrylate  particles�”  Spirometry,  PEFR, 
NSIC, and SIC were not reported�
Orthopedic exposures
Lee (Lee, 1984) reported a 25-year-old female anesthetist 
who experienced headache and chest tightness during 
her first operating room exposure to “bone cement vapor�” 
She was exposed to the “same substance” 6 months later 
and  developed  headache,  dizziness,  palpitation,  tight-
ness in the chest, and erythema on her face, arms, and 
neck� Her vital signs were immediately abnormal (blood 
pressure [BP]: 210/110 mm Hg; heart rate [HR]: 185 beats/
min;  respiratory  rate  [RR]:  36/min),  but  normalized 
within 30 minutes and she recovered “without complica-
tions�” No testing was performed�
Scolnick  and  Collins  (Scolnick  and  Collins,  1986) 
reported a 31-year-old female trainee scrub nurse who 
experienced “bifrontal headache, nausea and lighthead-
edness  “during  her  first  two  orthopedic  procedures” 
utilizing “Surgical Simplex P” bone cement (reported to 
contain 97% MMA monomer and 3% additives such as 
N,N-dimethyl-p-toluidine  and  hydroquinone)�  “Within 
minutes” of her third exposure to Simplex P, she devel-
oped diffuse erythroderma, dyspnea, hypertension, head-
ache, and diffuse neurological symptoms� She remained 
in the operating room for about 30 minutes, standing 
within 2 feet from the orthopedic cement mixing bowel, 
before seeking medical attention� Her initial vital signs 
were abnormal (BP: 180/100 mm Hg; HR: 120 beats/min; 
RR: 26/min), which normalized within 30 minutes after 
receiving subcutaneous epinephrine� Spirometry, PEFR, 
NSIC,  and  SIC  were  not  performed�  On  2  subsequent 
days, air sampling for MMA in the operating room “near 
the  mixing  table  during  an  operation”  reported  MMA 
levels of 0�4–1�5 ppm monitored over 15-minute periods 
(sampling method not described)�
Pickering  et  al�  (Pickering  et  al�,  1986)  reported 
respiratory  effects  in  a  56-year-old  female  orthopedic 
surgical  nurse  who  developed  cough,  wheezing  and 
breathlessness shortly after beginning use of Palacos® R 
bone cement “in which copolymer methyl acrylate and 
gentamicin are mixed with MMA�” Over a period of more 
than  11  years,  she  had  repeatedly  worked  with  other 
MMA-containing  bone  cements  (e�g�,  CMW®)  without 
experiencing similar respiratory effects� Her symptoms 
resolved when she went on holiday and “recurred imme-
diately” when she returned to work� Physical examination 
was  not  described�  Total  IgE  was  218  kU/L  and  “skin 
tests” to “common allergens” were negative� Spirometry 
was normal; PEFR and NSIC were not reported�
SIC was positive (FEV1 fell 25% at 6 hours) after work-
place simulation “identical with the normal procedure 
in the operating theatre,” but not during a placebo test� 
During SIC, MMA levels were measured by infrared gas 
analyzer; MMA levels reached 374 ppm during the first 2 
minutes when bone cement was mixed on an open trol-
ley and 76 ppm when it was mixed in a fume cabinet�
Reynaud-Gaubert et al� (Reynaud-Gaubert et al�, 1991) 
reported OA in a 39-year-old female orthopedic nurse 
with a history of seasonal rhinitis and conjunctivitis who 
developed asthma after working for an unstated duration 
with Palacos® bone cement containing gentamicin� SPT 
was  positive  for  common  allergens  (e�g�,  mites,  feath-
ers,  and  pollen)�  Spirometry  was  “normal,”  inhalation 
challenge  with  acetylcholine  was  “positive…a  typical 
asthmatic response” and PEFR was not performed� SIC 
was positive (25% fall in FEV1 after 30 minutes) after work 
simulation with Palacos® and “liquid MMA�” Asthma did 
not recur after the Palacos® with gentamicin was replaced 
by a different brand of bone cement (not identified)�
Kirby et al� (Kirby et al�, 2003) reported a 48-year-old 
female radiology technologist with a history of asthma, 
but no prior exposure to MMA or pMMA, who experi-
enced chest tightness while in an operating room where 
bone  cement  was  being  mixed�  (The  report  described 
exposure  to  “pMMA  vapors�”)  Symptoms  improved 
within  5  minutes  of  leaving  the  room  and  worsened 
upon her return� She was referred to an emergency room 
where she had shortness of breath, wheeze, watery eyes, 
and rhinorrhea� Her vital signs were BP: 132/90 mm Hg; 
HR: 100 beats/min; RR: 24/min� Spirometry, PEFR, NSIC, 
and SIC were not reported�
Other exposures
Kennes et al� (Kennes et al�, 1981) reported a 33-year-old 
male  smoker  who  developed  dry  cough,  rhinitis,  and 
asthma after 6 months of working and living on site in a 
factory that manufactured electrical equipment� His jobs 
included cutting Plexiglas plates, manipulating phospho-
rescent products, soldering aluminum, and spraying epoxy 
resin paints� On physical examination he had obstructive 
rhinitis with polyposis, wheezing, and severe breathless-
ness�  Spirometry  showed  “marked  obstructive  airways 
disease, reversible after inhalation of sympathomimetic 
amines�”  Laboratory  results  included  blood  eosinophil 
count of 747 cells/mm3; “numerous” eosinophils in the 
sputum; low total IgE (4 kU/L); and negative specific IgE 
(RAST) for common allergens, Aspergillus fumigatus, and 
Candida albicans; and negative “skin tests” (not otherwise 
specified)� PEFR and NSIC were not performed�
SIC was performed for five different workplace simula-
tions: positive (FEV1 fell 43%, FVC fell 18% at 30 minutes) 
after he “handled plexiglass shavings dust,” with “greater 
immediate and a late asthmatic response” on retesting 2 Methyl methacrylate and respiratory sensitization  259
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days later; positive (“immediate asthmatic response”) after 
“painting with TDI varnish”; negative after soldering with 
aluminum wires, painting with epoxy resin, and handling 
phosphorescent powder�
Savonius et al� (Savonius et al�, 1993;) reported find-
ings in 3152 patients evaluated for occupational respi-
ratory disease (pneumoconiosis not included)� MMA 
exposure was associated with 3 of 880 cases diagnosed 
as having OA/respiratory disease� Two of those three 
are described below�
Patient M-1 was a 48-year-old female plate engraver 
who developed “respiratory distress” along with sneez-
ing, rhinorrhea, and nasal stuffiness after 92 months of 
“occasionally” using MMA-containing glue� Total blood 
IgE was 88 kU/L; SPT (common allergens) and acrylate 
patch tests were negative� Spirometry, PEFR, and NSIC 
were  not  reported�  SIC  was  positive  (PEFR  fell  24%  8 
hours post exposure) after 30-minute work simulation 
spreading glue� Her symptoms persisted after the glue 
was  replaced  with  cyanoacrylate  glue�  Symptoms  per-
sisted after she quit her job�
Patient  M-2  was  a  32-year-old  male  smoker  who 
worked  as  a  hearing  device  assembler  and  developed 
“respiratory  symptoms”  diagnosed  as  asthma  after  a 
month of daily exposure to “MMA�” Total blood IgE was 
9 kU/L; SPT (common allergens) and acrylate patch tests 
were negative� Spirometry and PEFR were not reported; 
NSIC was positive (“change in the reactivity of the air-
ways in the histamine test”)� SIC was “negative” (PEFR 
fell 15%) after grinding “a piece of methacrylate” in an 
exposure chamber�
Lozewicz et al� (Lozewicz et al�, 1985) reported seven 
cases of occupational asthma, of whom two had been 
exposed  to  MMA-containing  materials�  One  of  those 
patients, Patient 7, was a 52-year-old male railway cable 
joiner who described headache, sweating, and lassitude 
when working with an “acrylic cold curing resin system 
containing MMA,” He had smoked “for many years” and 
reported episodes of cough and wheeze that were “not 
clearly work related�” The duration of exposure before 
onset of symptoms was not specified� Spirometry was not 
reported� PEFR “indicated asthma,” there was “no fall in 
FEV1” following histamine inhalation challenge, and SIC 
was negative “using the resin�” SPT was negative for com-
mon inhalant allergens�
Wittczak et al� (Wittczak et al�, 2003) reported a 44-year-
old, female secretary who had a 2-year history of rhinor-
rhea, dyspnea, and coughing attacks that occurred 15–20 
minutes  after  making  photocopies  using  xerographic 
toner  containing  “polystyrene-n-butyl  methacrylate, 
polystyrene-n-butyl  acrylate,  etc�”  The  patient  reported 
only work-related symptoms� Physical examination and 
routine laboratory tests were normal� Total IgE was “low” 
(18�04 ku/L) and SPT (common allergens) was negative� 
NSIC (histamine inhalation challenge) showed bronchial 
hyperreactivity� Spirometry and PEFR were not reported� 
SIC was positive after 18 minutes of photocopying (FEV1 
fell  24%  at  1  hour)  and  after  exposure  (duration  not 
described) to “thermally activated (80°C) MMA” (FEV1 fell 
30% at 1 hour), but negative after exposure to thermally 
activated polystyrene� Nasal lavage eosinophils increased 
24  hours  after  photocopying  and  “thermally  activated 
(80°C) MMA�”
Discussion
Methyl methacrylate is a respiratory irritant and dermal 
sensitizer  that  has  been  associated  with  occupational 
asthma in a small number of case reports� Those reports 
have  raised  concerns  that  MMA  might  also  act  as  a 
human respiratory sensitizer, a category of chemicals of 
much public health concern because of their potential to 
cause substantial morbidity� This concern is of particular 
importance because of the high volume of MMA produc-
tion and the large numbers of workers and others who 
might be exposed� To better understand that possibility, 
this review was undertaken to update the literature and 
evaluate the weight of evidence that MMA causes respira-
tory sensitization�
Only a limited number of metabolic, in silico and in 
chemico, studies exist that provide insights into the respi-
ratory sensitization potential of MMA� From a physical 
chemistry  perspective,  its  relatively  low  electrophilicity 
and  relatively  high  water  solubility  indicate  that  MMA 
should  be  expected  to  have  low  sensitizing  potential 
as  compared  to  other  acrylates  and  methacrylates� 
Experimental data also indicate that α-methyl substitu-
tion of an ester, such as MMA, decreases its reactivity 
compared  to  corresponding  unsubstituted  esters,  thus 
further supporting expectations that MMA would have 
comparatively low sensitizing potential� In addition, SAR 
studies found that esters have generally little or no activ-
ity as respiratory sensitizers and that LMW compounds 
with only one reactive functional group, such as MMA, 
pose a low respiratory sensitization hazard� Finally, SAR 
analyses using a model with a reported specificity of 99% 
for respiratory sensitizers judged MMA to be “inactive�” 
Taken  together,  these  studies  lend  substantial  weight 
of evidence that MMA should not be expected to cause 
respiratory sensitization�
The sensitization potency of MMA has only rarely been 
tested in vitro� In cellular response assays, MMA demon-
strated weak, transient, and mainly nonspecific stimula-
tion of cytokine production and gave no evidence that 
lymphocyte transformation was induced� Although lim-
ited, these study findings provide no evidence that MMA 
should be expected to cause respiratory sensitization�
Extensive  in  vivo  animal  testing  has  evaluated  the 
capacity of MMA to cause contact skin sensitization, but 
such studies provide little insight to its potential for respi-
ratory sensitization� Direct testing for inhalation sensitiza-
tion in guinea pigs and mice has not been reported, but 
LLNA has been performed� The LLNA results indicate that 
MMA has low sensitizing potency, substantially less than 
that of agents linked to respiratory sensitization� Because 
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as its most important factor for induction and elicitation 
of respiratory sensitization (Kimber et al�, 2007), its low 
potency provides further reason to predict that MMA does 
not act as a respiratory sensitizer�
Human studies comprise a larger and broader body of 
evidence� We identified one cohort and five cross-sectional 
studies  of  primary  MMA  workers,  two  cross-sectional 
studies of MMA-exposed dental workers, two cross-sec-
tional studies of workers exposed in other industries, and 
four mortality studies of MMA workers� Taken together, 
those studies provide evidence of respiratory irritation, 
but not airway sensitization or occupational asthma�
Nineteen case reports described occupational asthma, 
laryngitis,  or  hypersensitivity  pneumonitis  in  MMA-
exposed workers, but it remains uncertain whether any 
reflected  MMA-induced  sensitization�  Most  cases  had 
been exposed to mixtures of LMW sensitizers and irritants, 
or their exposures were not fully described� Specific chal-
lenge testing was performed in 13 of the 19 cases� Of those, 
three had negative tests� Two others had positive SIC, but 
had not been tested with MMA monomer� Another three 
were tested at high MMA levels that would have caused sig-
nificant irritation: two were tested with Palacos® in a man-
ner previously shown to achieve levels up to 1500 ppm; 
the third was tested with “MMA” heated to 80°C, a process 
that would have resulted in very high air concentrations� 
The final five case underwent SIC testing with “impure” 
mixtures  of  methacrylates  that  were  not  analyzed,  but 
probably contained “many additional acrylates��� additives 
and additional impurities” (Kanerva, 1993)� Together and 
separately, these reports provide little evidence that MMA 
is a respiratory sensitizer� Due to high exposure levels that 
occurred during testing, it is not possible to distinguish 
irritation versus sensitization� And because most SIC were 
conducted using uncharacterized mixtures of sensitizers 
and irritants, it is not possible to attribute the observed 
effects to MMA�
The difficulty of interpreting the results of SIC con-
ducted using incompletely characterized test chemicals 
and unexpectedly high exposure levels is reflected in a 
case report (not included above) that might have wrongly 
led to an inference of MMA-induced asthma� Vallieres 
et al� (Vallieres et al�, 1977) described a spray painter with 
progressive  rhinitis  and  asthma  beginning  one  month 
after starting to work with a paint containing 93% MMA, 
1�4% dimethyl ethanolamine (DMEA), 0�6% 1,4-dioxane, 
and  small  amounts  of  pigment�  SIC  testing  was  per-
formed by spraying a liter of test liquid in a “small, poorly 
ventilated room” over 13–14 minutes; air levels were not 
measured�  SIC  was  positive  with  paint  (FEV1  fell  29% 
immediately, and 23% at 8 hours) and with a 2% aqueous 
solution of DMEA (FEV1 fell 58% immediately, and 27% at 
8 hours)� By contrast, SIC was negative with 100% MMA 
and with a 0�6% aqueous solution of 1,4-dioxane� Skin 
prick tests with “high concentrations” of DMEA caused 
similar  wheal-and-flare  response  in  the  case  subject 
and three unexposed controls, suggesting an “irritative 
effect�”
The Vallieres report described what might have seemed 
to be a “classic” asthmatic response to MMA, but was actu-
ally not MMA related� Moreover, although the SIC response 
to DMEA suggested a sensitizer-induced response, there 
are no other reports of DMEA-induced allergy; its strong 
irritating  capacity,  however,  is  well  recognized  (Klonne 
et al�, 1987; Leung and Blaszcak, 1998; Smyth et al�, 1951)� 
And despite a relatively low vapor pressure (4 mm Hg at 
20°C; New Jersey Department of Health, 2010), high air 
concentrations of DMEA would be expected after spraying 
a liter in a small, closed space� Thus, this case illustrates 
that without full analysis and testing of an MMA-containing 
mixture, it may not be possible to correctly identify the 
agent causing a positive SIC� And without adequate air 
monitoring,  it  may  also  not  be  possible  to  distinguish 
effects due to irritation versus sensitization�
It  is  notable  that  despite  the  very  large  numbers  of 
MMA-exposed workers worldwide, there have been few 
documented cases of MMA-related occupational asthma� 
Moreover,  none  of  the  case  reports  reviewed  above 
described workers employed in the primary MMA indus-
tries,  where  sophisticated  industrial  hygiene  controls 
would be expected� To the contrary, all of the cases were 
exposed in secondary industries likely to lack adequate 
exposure controls: eight case reports involved dental work, 
five case reports involved operating room personnel, and 
four involved clerical and craft work� Lack of exposure data 
for most activities in the secondary MMA industries makes 
generalizations uncertain, but it seems likely that these 
workers  were  more  subject  to  high  exposures  because 
of inadequate industrial hygiene and uncontrolled work 
practices� In addition, fine work such as dental procedures 
and  nail  sculpting  may  require  that  MMA-containing 
materials be used close to the worker’s breathing zone� 
Thus, it would not be surprising if these workers were at 
risk for frequent high-level irritant exposures�
Accordingly,  the  weight  of  evidence,  both  experi-
mental  and  observational,  argues  that  MMA  is  not  a 
respiratory sensitizer� However, there is more than suf-
ficient evidence that it can act as a human respiratory 
irritant and as such, it may also cause irritant-induced 
occupational asthma� The distinction between the two 
mechanisms (i�e�, irritant versus sensitizer) has impor-
tant implications for workplace engineering controls and 
public health�
Without regard to underlying mechanisms of injury, 
our review also suggests important actions that should 
be taken to prevent adverse effects of “MMA exposure,” 
especially among workers in secondary MMA industries� 
Suppliers and producers of MMA-containing dental, sur-
gical, and cosmetic products should provide more infor-
mative MSDS and labels, including complete descriptions 
of  mixture  components�  Operating  rooms  and  dental 
laboratories should be equipped with vacuum exhaust 
mixing bowls or negative-pressure hoods for preparation 
of bone cement and dental composites� Other workers 
using  MMA-based  composites  should  be  instructed  in 
appropriate ways to increase ventilation and minimize Methyl methacrylate and respiratory sensitization  261
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exposures� Finally, there is need to ensure more frequent 
exposure monitoring of MMA workers, including a focus 
on  peak  excursions  rather  than  time-weighted-average 
exposures, which may not adequately identify the actual 
risks of working with volatile irritants such as MMA�
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